Docstoc

Lung Cancer

Document Sample
Lung Cancer Powered By Docstoc
					                         FINAL DRAFTDRAFT




                       Lung Cancer

       Data Definitions for Minimum Core Data Set


Definitions developed by ISD Scotland in Collaboration with the Regional
                           Cancer Networks




                Version 2.1: October 2010
DOCUMENT CONTROL SHEET

Key Information

Title                                          Lung Cancer - Data Definitions for
                                               Minimum Core Dataset
Date Published/Issued                          20 January 2010
Date Effective From                            01 January 2010
Version/Issue Number                           V2
Document Type                                  Guidance
Document status                                Final
Author                                         Cancer Definitions Manager

Revision History

Version       Date           Summary of Changes             Name          Changes
                                                                          Marked
2             20/01/10       Final                          JH
2.1           02/09/10       Changes Agreed at six-         JH            See page iv
                             month review meeting on
                             02/09/2010. Changes to
                             be retrospective i.e. for
                             patients diagnosed from
                             01/01/2010



Approvals This document requires the following approvals.

Name                           Title                                     Date
Dr Ron Fergusson               Lead Clinician – Consultant in            02/09/10
                               Respiratory Medicine
Jean Harvey                    Cancer Definitions Manager                02/09/10




          National Data Definitions for Minimum Core Data Set for Lung Cancer
                        Developed by the ISD, 2010, Version 2.1
CONTENTS

  PREFACE ............................................................................................................................................ i
  NOTES FOR IMPLEMENTATION OF CHANGES.........................................................................ii
  CONVENTIONS ................................................................................................................................ii
  CRITERIA FOR INCLUSION OF PATIENTS IN AUDIT..............................................................iii
  REVISIONS TO DATASET SINCE IMPLEMENTATION ............................................................ iv
  DATABASE SPECIFICATION .......................................................................................................vii
Section 1: Patient Identifiers........................................................................ 1
  Person Family Name ........................................................................................................................... 2
  Person Given Name............................................................................................................................. 3
  Patient Postcode at Diagnosis {Cancer}.............................................................................................. 4
  Date of Birth........................................................................................................................................ 5
  Person Sex at Birth .............................................................................................................................. 6
  Location of Diagnosis {Cancer} ......................................................................................................... 7
  Health Record Identifier ...................................................................................................................... 8
  CHI Number ........................................................................................................................................ 9
Section 2: Referral Details and Hospital Clinicians ................................. 10
  Cancer Registration Incidence Date {Cancer} .................................................................................. 11
  Date of Cancer Referral..................................................................................................................... 12
  Date Referral Received...................................................................................................................... 13
  Source of Cancer Referral ................................................................................................................. 14
  Urgency of Cancer Referral .............................................................................................................. 15
  Clinician 1-4 ...................................................................................................................................... 16
  Specialty of Clinician 1-4.................................................................................................................. 17
  Date of First Seeing Clinician 1-4 {Lung Cancer} ........................................................................... 19
  Date Discussed by Care Team (Pre-treatment) ................................................................................. 20
  Care Team Meeting Actions Recorded (Pre-treatment) .................................................................... 21
  Reason Not Discussed by Care Team (Pre-treatment) ...................................................................... 22
Section 3: Diagnostic Procedures, Staging and Assessment ................ 23
  Date of Chest x-Ray .......................................................................................................................... 24
  Date of CT/MRI Thorax.................................................................................................................... 25
  Date of Integrated FDG-PET/CT (PET/CT) Scan............................................................................. 26
  Date of CT/MRI Brain ...................................................................................................................... 27
  Date of Bronchoscopy {Lung Cancer} ............................................................................................. 28
  Date of Endobronchial Ultrasound (EBUS) ...................................................................................... 29
  Date of Image Guided Biopsy or FNA of Lung ................................................................................ 30
  Other Tissue Diagnosis Specimen Site.............................................................................................. 31
  Date of Other Tissue Diagnosis......................................................................................................... 32
  Laterality {Cancer} ........................................................................................................................... 33
  Origin of Tumour .............................................................................................................................. 34
  Site of Tumour................................................................................................................................... 35
  Date of Diagnosis {Cancer} .............................................................................................................. 36
  Most Valid Basis of Diagnosis {Cancer}.......................................................................................... 37
  Date of Mediastinoscopy................................................................................................................... 39
  Date of Thoracotomy/Thoracoscopy (VATS) (Pre-treatment).......................................................... 40
  TNM Tumour Classification (Clinical) ............................................................................................. 41
  TNM Nodal Classification (Clinical) ................................................................................................ 43
  TNM Metastases Classification (Clinical)......................................................................................... 44
  Synchronous Primary Tumours......................................................................................................... 45
  TNM Tumour Classification (Clinical) (Pleural Mesothelioma)....................................................... 46
  TNM Nodal Classification (Clinical) (Pleural Mesothelioma).......................................................... 48
  TNM Metastases Classification (Clinical) (Pleural Mesothelioma) .................................................. 49
  WHO/ ECOG Performance Status .................................................................................................... 50
  Seen by Clinical Nurse Specialist {Lung Cancer / Mesothelioma} .................................................. 51
Section 4: Pathology (Diagnostic)............................................................. 52
  Location Code {Cancer Pathology} .................................................................................................. 52
  Date Histo/ Cytopathological Specimen Taken................................................................................. 55
  Histology/Cytology (Diagnostic/Pre-Surgery) .................................................................................. 56
          National Data Definitions for Minimum Core Data Set for Lung Cancer
                         Developed by the ISD, 2010, Version 2.1
  Reason Histology/Cytology not Performed....................................................................................... 58
Section 5: Surgery and Post-Resection Pathology.................................. 59
  Type of First Cancer Treatment ........................................................................................................ 60
  Date of First Cancer Treatment ......................................................................................................... 62
  Location Code {Cancer Surgery}...................................................................................................... 63
  Surgery Performed ............................................................................................................................ 64
  Date of Surgery ................................................................................................................................. 65
  Type of Surgery................................................................................................................................. 66
  Surgical Approach............................................................................................................................. 67
  Therapeutic Thoracoscopy (VATS) .................................................................................................. 68
  Date of Therapeutic Thoracoscopy ................................................................................................... 69
  Date Discussed by Care Team (Post-Surgery)} ................................................................................ 70
  Reason Not Discussed by Care Team (Post-Surgery) ....................................................................... 71
  Care Team Meeting Actions Recorded (Post-Surgery) ..................................................................... 72
  Histology (Post-Surgical) .................................................................................................................. 73
  Residual Tumour ............................................................................................................................... 75
  TNM Tumour Classification (Pathological) (Lung Cancer) ............................................................. 76
  TNM Nodal Classification (Pathological) (Lung Cancer)................................................................. 78
  TNM Metastases Classification (Pathological) (Lung Cancer)......................................................... 79
  TNM Tumour Classification (Pathological) (Pleural Mesothelioma) ............................................... 80
  TNM Nodal Classification (Pathological) (Pleural Mesothelioma) .................................................. 82
  TNM Metastases Classification (Pathological) (Pleural Mesothelioma)........................................... 83
Section 6: Radiotherapy............................................................................. 84
  Radiotherapy ..................................................................................................................................... 85
  Patient Eligible for Continuous Hyperfractionated Accelerated Radiotherapy (CHART)................ 86
  Radiotherapy Course Type 1-3.......................................................................................................... 87
  Site of Radiotherapy (Courses 1- 3) .................................................................................................. 88
  Date Treatment Started {Cancer} (Radiotherapy) 1-3 ...................................................................... 89
  Date Treatment Completed {Cancer} (Radiotherapy) 1-3 ................................................................ 90
  Radiotherapy Dose: Total Administered {Cancer} 1-3..................................................................... 91
  Radiotherapy Fractions: Total Administered {Cancer} 1-3 .............................................................. 92
  Type of Radiotherapy Fractionation Schedule 1-3............................................................................ 93
Section 7: Systemic Therapy ..................................................................... 94
  Treatment Status {Cancer} (Systemic Therapy) ............................................................................... 95
  Systemic Therapy Type {Cancer} 1-3 .............................................................................................. 96
  Systemic Therapy Agent (Lung Cancer) 1-3..................................................................................... 97
  Chemotherapy Total Number of Cycles Administered {Cancer} 1-3............................................... 98
  Date Treatment Started {Cancer} (Systemic Therapy) 1-3 ............................................................... 99
  Date Treatment Completed {Cancer} (Systemic Therapy) 1-3....................................................... 100
Section 8: Other Therapy ......................................................................... 101
  Date of Endobronchial Treatment ................................................................................................... 102
Section 9: Clinical Trials .......................................................................... 103
  Participant in Clinical Trial ............................................................................................................. 104
Section 10: Follow-Up and Death ............................................................ 105
  Date of Death .................................................................................................................................. 106
  Underlying Cause of Death ............................................................................................................. 107
APPENDIX 1................................................................................................... 1
  DATABASE SPECIFICATION AND VALIDATIONS ................................................................... 1




              National Data Definitions for Minimum Core Data Set for Lung Cancer
                            Developed by the ISD, 2010, Version 2.1
PREFACE
The first minimum core dataset for patients with lung cancer was published in 2001

following the establishment of the first Scottish Intercollegiate Guideline Network

(SIGN) clinical guideline for the management of lung cancer which was published in

1998. The establishment of the Clinical Standards Board for Scotland (CSBS) was

also instrumental in the development of this dataset. Prospective audit of lung

cancer has occurred in Scotland over the last decade using this dataset and has

resulted in a number of significant improvements in lung cancer services.



A number of new processes have required the original lung cancer dataset to be

updated. The first was the second SIGN lung cancer guideline which was published

in association with a UK (NICE) guideline in 2005. More recently the Clinical

Standards Board has been superseded by the NHS QIS guidance which was

published in 2008. Both these documents have outlined how lung cancer should be

managed in modern times and a new dataset to capture this data has been

formulated.



The development of newer technologies such as positron emission tomography

(PET) scanning and endobronchial ultrasound (EBUS) has changed the way that

lung cancer patients are investigated and treated. It is hoped that the new lung

cancer dataset developed collaboratively between the three cancer networks and

ISD will allow for accurate and meaningful prospective audit in lung cancer to

continue. It is also hoped that the production of high quality prospective audit

reports will allow for improvements in lung cancer services for patients in the future.


Dr Ron Fergusson
Consultant in Respiratory Medicine




         National Data Definitions for Minimum Core Data Set for Lung Cancer
                       Developed by the ISD, 2010, Version 2.1

                                       Page i
NOTES FOR IMPLEMENTATION OF CHANGES
The following changes should be implemented for all patients who are diagnosed
with lung cancer on or after 1 January 2010, who are eligible for inclusion in the lung
and mesothelioma audit.

Changes to definitions fall into the following categories:

•   to address problems with ongoing audit and standardise data definitions, where
    feasible, between different cancer sites
•   to address problems with existing definitions
•   to address revisions to SIGN recommendations
•   to allow NHS Quality Improvement Scotland standards to be measured where
    feasible
•   to collect core cancer registration data items.

Changes to definitions are highlighted at the foot of a page.

If you have difficulties in using individual definitions within this document please
contact Jean Harvey, Cancer Definitions Manager
(Jean.Harvey@isd.csa.scot.nhs.uk).


General Enquiries on the Collection of the Minimum Core Data Set
If you have any comments on the attached data definitions ISD would welcome your
feedback. Please contact:

               Brian Murray
               Cancer Information Coordinator
               ISD Scotland
               Tel: 0131 275 6629
               e-mail: brianmurray@nhs.net

CONVENTIONS
In the following definitions the layout for each item is standard. Two conventions
have been used in the document as follows:

• {curly brackets} - definition relates to one specific named data set
• 'described elsewhere' - indicates there is a definition for the named item within
  this document




         National Data Definitions for Minimum Core Data Set for Lung Cancer
                        Developed by ISD, 2010, Version 2.1

                                       Page ii
CRITERIA FOR INCLUSION OF PATIENTS IN AUDIT
To facilitate national comparisons the same patients must be audited throughout
Scotland. The following eligibility criteria have been documented for this purpose.

Include
• All patients with a confirmed new primary cancer of the bronchus, lung or trachea
   (ICD code C33-34). This includes patients who have had a previous primary
   malignancy of any site or a concurrent primary malignancy of another site.
• All patients with Mesothelioma.(ICD morphology code:
          9050/3, Mesothelioma NOS
          9051/3 , Fibrous/Desmoplastic/Sarcomatoid/Spindled Mesothelioma
          9052/3, Epithelioid
          9053/3). Biphasic Mesothelioma
• All patients who have received any part of their treatment within a health
   board/region even if their normal residence lies outwith Scotland. For patients
   who receive part of their diagnosis / treatment privately and part on the NHS,
   should be included and the data recorded for the part of their diagnosis /
   treatment performed under the NHS.

Exclude
• patients where the origin of the primary is uncertain
• patients with recurrent disease (as opposed to a new primary tumour)
• patients with metastatic lung disease from another primary cancer site




NB: All treatments given as part of the initial treatment plan
plus second-line treatment received within six months of
diagnosis should be recorded.




         National Data Definitions for Minimum Core Data Set for Lung Cancer
                        Developed by ISD, 2010, Version 2.1

                                      Page iii
REVISIONS TO DATASET SINCE IMPLEMENTATION
Updated after six-month review 2/9/2010 but changes to
be retrospective (for patients diagnosed from 1/1/2010)
New Data Items Added:
Page 34: New item added for ‘Origin of Tumour’
Page 51: New item added for ‘Seen by Clinical Nurse Specialist’


Data Items removed:
Lymph Nodes Type Submitted
Lymph Nodes Type Involved
Location Code (Radiotherapy)
Location code (Endobronchial Treatment)
Endobronchial Treatment Type
Reason(s) for Delay in Starting First Treatment

Other minor changes are:

Database specification:
Site of Radiotherapy: Changed field name to RADIOSITE 1-3 and
RADIOSITEOTHER 1-3

Type of Fractionation Schedule: Added 1-3 to FRACSCHED and FRACSCHED98

Systemic Therapy Type: Added 1-3 to CHEMTYPE.

Systemic Therapy Agent: Added 1-3 to CHEMAGENT and CHEMAGENT98

Dataset:
Date Referral Received: Paragraph added regarding inter-consultant referrals (i.e.
incidental findings etc).

Urgency of Referral: ‘Soon’ removed.

Cancer Registration Incidence Date: Note added stating that for the purposes of
national audit, death certificate only cases are not included.

Date of Chest x-Ray:
   Definition changed to ‘This is the date of the first abnormal x-ray which suggests
   a diagnosis of lung cancer or mesothelioma’.
   Notes for users changed to say this can happen in primary or secondary care.

Date of Image Guided Biopsy or FNA: Added ‘of Lung’ to title.

Date of Thoracotomy/Thoracoscopy (Pre-treatment): Add (VATS) to title.

Laterality: Explanatory note added to midline stating that Central tumours i.e. those
whose point of origin cannot be assigned to left or right are regarded as midline. For
lymph nodes, station 7 is the only central one. If no station or laterality is indicated,
record as 'Not known'.

Site of Tumour: Only C48.2 and C67.7 marked as Mesothelioma only

         National Data Definitions for Minimum Core Data Set for Lung Cancer
                        Developed by ISD, 2010, Version 2.1

                                       Page iv
Histology/Cytology (Diagnostic/Pre-surgery): Note added that pathology taken
after a patient had initially refused further investigation or whose first treatment was
watch and wait can also be recorded.

Type of First Cancer Treatment:
   Code 5 changed from Endoscopic to Endobronchial. Endobronchial treatment
   types added as explanatory notes.
   Code 6 Hormone Therapy removed.
   Code 13 added for Biological Therapy and types of biological treatments added
   as explanatory notes.
   Last paragraph about endoscopic treatment removed.
   Note added stating that steroids, drainage etc are not classed as first treatment if
   more substantive treatment is given.

Histology/Cytology (Diagnostic/Pre-Surgery): Note added that pathology taken
after a patient had initially refused further investigation or whose first treatment was
watch and wait can also be recorded.

Histology (Post-Surgical): Note added that pathology taken after a patient had
initially refused further investigation or whose first treatment was watch and wait can
also be recorded.

TNM Tumour Classification (Pathological) (Lung Cancer): Definition changed to
‘A record of the size and extent of the tumour following resection of the primary
cancer’ and Para 1 about clinical TNM in notes for users removed.

Radiotherapy: Under Notes for Users, the part stating that radiotherapy recorded is
that which was given at the time of the initial treatment episode is removed.

Date Treatment Started (Radiotherapy): References to chemotherapy, biological
therapy, hormonal therapy, implant or other therapy removed.

Date Treatment Completed (Radiotherapy): References to chemotherapy,
biological therapy, hormonal therapy, implant or other therapy removed.

Type of Fractionation Schedule: Note added to allow for three courses of
radiotherapy

Treatment Status (Systemic Therapy): Definition changed from specific treatment
to systemic treatment.

Systemic Therapy Type: Definition changed to ‘The type of course of
chemotherapy or biological drugs administered for the treatment of the cancer’.

Systemic Therapy Agent:
   & NSCLC added to explanatory note for code 15.
   New code 17 added for Carboplatin/Pemetrexed for NSCLC.
   Definition changed to ‘The type of chemotherapy or biological therapy used
   either alone or in combination to treat lung cancer’.
   Date Treatment Started (Systemic Therapy): References to radiotherapy,
   hormonal therapy, implant or other therapy removed.
   Date Treatment Completed (Systemic Therapy): References to radiotherapy,
   hormonal therapy, implant or other therapy removed

Underlying Cause of Death:

         National Data Definitions for Minimum Core Data Set for Lung Cancer
                        Developed by ISD, 2010, Version 2.1

                                       Page v
   Changed field length to 4
   Changed format to ann.n or ann.a e.g. C34.9

Appendix 1:
Added for database specification and validations.
.

NB: All treatments given as part of the initial treatment plan
plus second-line treatment received within six months of
diagnosis should be recorded.


                         Page inserted 3 September 2010




        National Data Definitions for Minimum Core Data Set for Lung Cancer
                       Developed by ISD, 2010, Version 2.1

                                     Page vi
DOWNLOAD FORMAT
To assist with downloading data to ISD for the National Quality Assurance
Programme and other agreed activities, all sites should be able export data
according to the following specification.


DATABASE SPECIFICATION

Data Item                             FIELD NAME                  Field       Size
                                                                  Type
Patient Identifiers
Person Family Name                    PATSNAME                    Character   35
Person Given Name                     PATFNAME                    Character   35
Patient Postcode at Diagnosis         PATPCODE                    Character    8
{Cancer}
Date of Birth                         DOB                         Date        10
Person Sex at Birth                   SEX                         Integer      1
Location of Diagnosis {Cancer}        HOSP                        Character    5
Health Record Identifier              UNITNUM                     Character   14
CHI Number                            CHINUM                      Character   10
Referral Details and Hospital Clinicians
Cancer Registration Incidence Date INCDATE                        Date        10
Date of Cancer Referral               REFDATE                     Date        10
Date Referral Received                REFRECDATE                  Date        10
Source of Cancer Referral             MREFER                      Character    2
Urgency of Cancer Referral            URGENCYREF                  Character    2
Clinician 1                           CLINAM1                     Character   20
Clinician 2                           CLINAM2                     Character   20
Clinician 3                           CLINAM3                     Character   20
Clinician 4                           CLINAM4                     Character   20
Speciality of Clinician 1             CLINSPEC1                   Character    3
Speciality of Clinician 2             CLINSPEC2                   Character    3
Speciality of Clinician 3             CLINSPEC3                   Character    3
Speciality of Clinician 4             CLINSPEC4                   Character    3
Date of First Seeing Clinician 1      FCLINDATE1                  Date        10
{Lung Cancer}
Date of First Seeing Clinician 2      FCLINDATE2                  Date        10
{Lung Cancer}
Date of First Seeing Clinician 3      FCLINDATE3                  Date        10
{Lung Cancer}
Date of First Seeing Clinician 4      FCLINDATE4                  Date        10
{Lung Cancer}
Date Discussed by Care Team           MDTDATE                     Date        10
(Pre-treatment)
Care Team Meeting Actions             MDTACTION                   Character    2
Recorded (Pre-treatment)
Reason not Discussed by Care          REASONNOMDT                 Character    2
Team (Pre-treatment)
Reason not Discussed by Care          REASONNOMDT98               Character   15
Team – Other, specify                                                          0
Diagnostic Procedures, Staging and Assessment
Date of Chest X-ray               XDATE                           Date        10
       National Data Definitions for Minimum Core Data Set for Lung Cancer
                      Developed by ISD, 2010, Version 2.1

                                    Page vii
Date of CT/MRI Thorax                   CTHORAXDATE                Date        10
Date of integrated FDG-PET/CT           PETDATE                    Date        10
(PET/CT) Scan
Date of CT/MRI Brain                    CTBRAINDATE                Date        10
Date of Bronchoscopy {Lung              BDATE                      Date        10
Cancer}
Date of Endobronchial Ultrasound        EBUSDATE                   Date        10
(EBUS)
Date of Image Guided Biopsy or          IMGUIDDATE                 Date        10
FNA of Lung
Other Tissue Diagnosis Specimen         OTHSPECSITE                Character    3
Site
Other Tissue Diagnosis Specimen         OTHSPECSITE98              Character   15
Site – Other, specify                                                           0
Date of Other Tissue Diagnosis          OTHTDDATE                  Date        10
Laterality {Cancer}                     SIDE                       Character    2
Origin of Tumour                        ORIGIN                     Numeric      2
Site of Tumour                          SITE                       Character    5
Site of Tumour – Other, specify         SITE98                     Character   15
                                                                                0
Date of Diagnosis {Cancer}              DIAGDATE                   Date        10
Most Valid Basis of Diagnosis           VALID                      Character    2
{Cancer}
Date of Mediastinoscopy                 MEDIASTDATE                Date        10
Date of Thoracotomy/Thorascopy          THORADATE                  Date        10
(VATS) (Pre-treatment)
TNM Tumour Classification               TLUNG                      Character    3
(Clinical) (Lung Cancer)
TNM Nodal Classification                NLUNG                      Character    2
(Clinical) (Lung Cancer)
TNM Metastases Classification           MLUNG                      Character    3
(Clinical) (Lung Cancer)
Synchronous Primary Tumours             MULTIPLE                   Character    3
TNM Tumour Classification               TMESO                      Character    3
(Clinical) (Pleural Mesothelioma)
TNM Nodal Classification                NMESO                      Character    2
(Clinical) (Pleural Mesothelioma)
TNM Metastases Classification           MMESO                      Character    2
(Clinical) (Pleural Mesothelioma)
WHO/ECOG Performance Status             PSTATUS                    Character    1
Seen by Clinical Nurse Specialist       CNS                        Character    2
{Lung Cancer / Mesothelioma}
Pathology (Diagnostic)
Location Code {Cancer Pathology}        PATHLAB                    Character    5
Date Histo/Cytopathological             PATHDATE                   Date        10
Specimen Taken
Histology/Cytology (Diagnostic/Pre-     HIST                       Character    2
Surgery)
        National Data Definitions for Minimum Core Data Set for Lung Cancer
                       Developed by ISD, 2010, Version 2.1

                                      Page viii
Reason Histology/Cytology not           REASONNOHIST                Character    2
Performed
Surgery and Post-Resection Pathology
Type of First Cancer Treatment          MODE1                       Character    2
Date of First Cancer Treatment          FIRSTTREATDATE              Date        10
Location Code {Cancer Surgery}          HOSPSURG                    Character    5
Surgery Performed                       SURG                        Character    2
Date of Surgery                         DSURG                       Date        10
Type of Surgery                         SURGTYPE                    Character    2
Type of Surgery – Other, specify        SURGTYPE98                  Character   15
                                                                                 0
Surgical Approach                 APPROACH                          Character    2
Therapeutic Thoracoscopy (VATS)   VATS                              Character    2
Therapeutic Thoracoscopy (VATS) – VATS98                            Character   15
Other, specify                                                                   0
Date of Therapeutic Thoracoscopy  VATSDATE                          Date        10
(VATS)
Date Discussed by Care Team       MDTPOSTSURGDATE                   Date        10
(Post-Surgery)
Reason not Discussed by Care      REASONNOMDTPOST                   Character    2
Team (Post-Surgery)               SURG
Reason not Discussed by Care      REASONNOMDTPOST                   Character   15
Team (Post-Surgery) – Other,      SURG98                                         0
specify
Care Team Meeting Actions         MDTACTPOSTSURG                    Character    2
Recorded (Post-Surgery)
Histology (Post-Surgical)         SURGHIST                          Character    2
Residual Tumour                   RESIDUAL                          Character    2
TNM Tumour Classification         PTLUNG                            Character    3
(Pathological) (Lung Cancer))
TNM Nodal Classification          PNLUNG                            Character    2
(Pathological) (Lung Cancer)
TNM Metastases Classification     PMLUNG                            Character    3
(Pathological) (Lung Cancer))
TNM Tumour Classification         PTMESO                            Character    3
(Pathological) (Pleural
Mesothelioma)
TNM Nodal Classification          PNMESO                            Character    2
(Pathological) (Pleural
Mesothelioma)
TNM Metastases Classification     PMMESO                            Character    2
(Pathological) (Pleural
Mesothelioma)
Radiotherapy
Radiotherapy                            RADIO                       Character    2
Patient Eligible for Continuous         CHART                       Character    2
Hyperfractionated Accelerated
Radiotherapy (CHART)
Radiotherapy Course Type 1              RADIOTYPE1                  Character        3



         National Data Definitions for Minimum Core Data Set for Lung Cancer
                        Developed by ISD, 2010, Version 2.1

                                      Page ix
Radiotherapy Course Type 2             RADIOTYPE2                  Character       3
Radiotherapy Course Type 3             RADIOTYPE3                  Character       3
Site of Radiotherapy                   RADIOSITE1                  Character       2
(Course 1)
Site of Radiotherapy                   RADIOSITE2                  Character       2
(Course 2)
Site of Radiotherapy                   RADIOSITE3                  Character       2
(Course 3)
Site of Radiotherapy                   RADIOSITEOTHER1             Character   150
(Course 1) – Other, specify
Site of Radiotherapy                   RADIOSITEOTHER2             Character   150
(Course 2) – Other, specify
Site of Radiotherapy                   RADIOSITEOTHER3             Character   150
(Course 3) – Other, specify
Date Treatment Started {Cancer}        RSRTDATE1                   Date         10
(Radiotherapy) 1
Date Treatment Started {Cancer}        RSRTDATE2                   Date         10
(Radiotherapy) 2
Date Treatment Started {Cancer}        RSRTDATE3                   Date         10
(Radiotherapy) 3
Date Treatment Completed {Cancer}      RCOMPDATE11                 Date         10
(Radiotherapy) 1
Date Treatment Completed {Cancer}      RCOMPDATE2                  Date         10
(Radiotherapy) 2
Date Treatment Completed {Cancer}      RCOMPDATE3                  Date         10
(Radiotherapy) 3
Radiotherapy Dose: Total               TOTDOSE1                    Numeric         5
Administered {Cancer} 1                                            (nn.nn)
Radiotherapy Dose: Total               TOTDOSE2                    Numeric         5
Administered {Cancer} 2                                            (nn.nn)
Radiotherapy Dose: Total               TOTDOSE3                    Numeric         5
Administered {Cancer} 3                                            (nn.nn)
Radiotherapy Fractions: Total          FRACTIONS1                  Numeric         2
Administered {Cancer} 1                                            (Integer)
Radiotherapy Fractions: Total          FRACTIONS2                  Numeric         2
Administered {Cancer} 2                                            (Integer)
Radiotherapy Fractions: Total          FRACTIONS3                  Numeric         2
Administered {Cancer} 3                                            (Integer)
Type of Radiotherapy Fractionation     FRACSCHED1                  Character       2
Schedule 1
Type of Radiotherapy Fractionation     FRACSCHED2                  Character       2
Schedule 2
Type of Radiotherapy Fractionation     FRACSCHED3                  Character       2
Schedule 3
Type of Radiotherapy Fractionation     FRACSCHED981                Character   150
Schedule – Other, specify 1
Type of Radiotherapy Fractionation     FRACSCHED982                Character   150
Schedule – Other, specify 2
Type of Radiotherapy Fractionation     FRACSCHED983                Character   150
Schedule – Other, specify 3
Systemic Therapy
Treatment Status {Cancer}              CHEM                        Character   2
        National Data Definitions for Minimum Core Data Set for Lung Cancer
                       Developed by ISD, 2010, Version 2.1

                                      Page x
(Systemic Therapy)
Systemic Therapy Type {Cancer} 1       CHEMTYPE1                   Character    2
Systemic Therapy Type {Cancer} 2       CHEMTYPE2                   Character    2
Systemic Therapy Type {Cancer} 3       CHEMTYPE3                   Character    2
Systemic Therapy Agent (Lung           CHEMAGENT1                  Character    2
Cancer) 1
Systemic Therapy Agent (Lung           CHEMAGENT2                  Character    2
Cancer) 2
Systemic Therapy Agent (Lung           CHEMAGENT3                  Character    2
Cancer) 3
Systemic Therapy Agent - Other,        CHEMAGENT981                Character   15
specify 1                                                                       0
Systemic Therapy Agent - Other,        CHEMAGENT982                Character   15
specify 2                                                                       0
Systemic Therapy Agent - Other,        CHEMAGENT983                Character   15
specify 3                                                                       0
Chemotherapy Total Number of           CYCLES1                     Numeric      3
Cycles Administered {Cancer} 1                                     (Integer)
Chemotherapy Total Number of           CYCLES2                     Numeric      3
Cycles Administered {Cancer} 2                                     (Integer)
Chemotherapy Total Number of           CYCLES3                     Numeric      3
Cycles Administered {Cancer} 3                                     (Integer)
Date Treatment Started {Cancer}        CHEMDATE1                   Date        10
(Systemic Therapy) 1
Date Treatment Started {Cancer}        CHEMDATE2                   Date        10
(Systemic Therapy) 2
Date Treatment Started {Cancer}        CHEMDATE3                   Date        10
(Systemic Therapy) 3
Date Treatment Completed               CHEMENDATE1                 Date        10
(Systemic Therapy) 1
Date Treatment Completed               CHEMENDATE2                 Date        10
(Systemic Therapy) 2
Date Treatment Completed               CHEMENDATE3                 Date        10
(Systemic Therapy) 3
Other Therapy
Date of Endobronchial Treatment        ENDODATE                    Date        10
Clinical Trials
Participant in Clinical Trials         TENTRY                      Character    2
Follow-Up and Death
Date of Death                          DOD                         Date        10
Underlying Cause of Death              COD                         Character    4




                                Pages revised 2/9/2010




        National Data Definitions for Minimum Core Data Set for Lung Cancer
                       Developed by ISD, 2010, Version 2.1

                                     Page xi
           Section 1: Patient Identifiers




National Data Definitions for National Minimum Core Data Set for Lung Cancers
                Developed by ISD Scotland, 2010 Version 2.1


                                     Page 1
Person Family Name
Common Name(s): Surname, Family name

Main Source of Data Item Standard: Government Data Standards Catalogue

Definition:
That part of a person's name which is used to describe family, clan, tribal group, or
marital association.

Field Name: PATSNAME
Field Type: Characters
Field Length: 35

Notes for Users:
Main Source of Data Item Standard: Government Data Standards Catalogue
The surname of a person represents that part of the name of a person indicating the
family group of which the person is part.
It should be noted that in Western culture this is normally the latter part of the name
of a person. However, this is not necessarily true of all cultures. This will, of course,
give rise to some problems in the representation of the name. This is resolved by
including the data item Name Element Position in the structured name indicating the
order of the name elements.

From SMR Definitions and Codes

Codes and Values: N/A

Related Data Items: N/A


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 2
Person Given Name
Common Name(s): Forename, Given Name, Personal Name

Main Source of Data Item Standard: Government Data Standards Catalogue

Definition:
The forename or given name of a person.

Field Name: PATFNAME
Field Type: Characters
Field Length: 35

Notes for Users:
Main Source of Data Item Standard: Government Data Standards Catalogue
The first forename of a person represents that part of the name of a person which
after the surname is the principal identifier of a person.

A person can have multiple occurrences of a given name, the order of which is
identified by the sub data item 'Name Element Position'.

Where the person's preferred forename is not the first forename, the related data
item 'Preferred Forename' should be used to indicate this.


Codes and Values: N/A

Related Data Items: N/A


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 3
Patient Postcode at Diagnosis {Cancer}
Main Source of Data Item Standard: Government Data Standards Catalogue

Definition:
Postcode of patient's usual place of residence on the date of diagnosis

Field Name: PATPCODE
Field Type: Characters
Field Length: Maximum 8


Notes for Users:
Postcode is included in BS7666 Address (GDSC) but there is also a separate Post
Code standard which will be populated from BS7666 Address Post Code.

This item can be derived from the date of diagnosis and patient address at that time

Codes and Values: N/A

Related Data Items:
Cancer Registration Incidence Date {Cancer}, Patient Address at Diagnosis {Cancer},
Address (BS7666)


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 4
Date of Birth

Main source of Data Item Standard: Government Data Standards Catalogue
                                               1




Definition:
The date on which a person was born or is officially deemed to have been born, as
recorded on the Birth Certificate.

Field Name: DOB
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
If the patient's date of birth is recorded differently on different occasions, the most
frequently used or latest date should be recorded.

The patient's full date of birth inclusive of the century should be recorded.

Codes and Values: N/A

Related Data Items: CHI Number

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                   Page 5
Person Sex at Birth
Common Name(s): Sex at Birth

Main Source of Data Item Standard: Derived from the nearest equivalent
Government Data Standards Catalogue standard ‘Person Gender at Registration’

Definition:
This is a factual statement, as far as is known, about the phenotypic (biological) sex
of the person at birth

Field Name: SEX
Field Type: Characters
Field Length: 1

Notes for Users:
A person’s sex has clinical implications, both in terms of the individual’s health and
the health care provided to them.

In the majority of cases, the phenotypic (biological) sex and genotypic sex are the
same and the phenotypic sex is usually easily determined. In a small number of
cases, accurate determination of genotype may be required.

Codes and Values:
 Code Value                                    Explanatory Notes
 0     Not known
 1     Male
 2     Female
 9     Not specified/Indeterminate             Where it has not been possible to determine
                                               if the person is male or female at birth, e.g.
                                               intersex / hermaphrodite.


Related Data Items: CHI Number


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 6
Location of Diagnosis {Cancer}
Main Source of Data Item Standard: The National Audit Cancer Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The patient's hospital of investigation in which the diagnosis of cancer was first
made.

Field Name: HOSP
Field Type: Characters
Field Length: 5

Notes for Users:
This may also be a GP surgery code if a biopsy was taken by a GP. This will be the
hospital/GP surgery where the sample was taken or the hospital at which the patient
was managed when the diagnosis was made.

Details of location codes for hospitals can be found in the "Definitions and Codes for
the NHS in Scotland" manual produced by ISD Scotland.

Location codes for hospitals are five character codes maintained by ISD Scotland
and the General Register Office (Scotland). The first character denotes the health
board, the next three are assigned and the fifth denotes the type of location
(H=hospital) e.g.

A111H=Crosshouse Hospital
G107H=Glasgow Royal Infirmary
X1010=Not applicable
X9999=Not recorded

If a patient was provisionally diagnosed at one hospital but transferred to another for
confirmation of the diagnosis only e.g. biopsy, then returns to the original hospital,
the first hospital should be recorded as the Location of diagnosis.

Codes and Values: N/A

Related Data Items: Health Record Identifier

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 7
Health Record Identifier
Common Name(s): Case Reference Number, CRN, Hospital Number

Main Source of Data Item Standard: Scottish Executive Health Department

Definition:
A Patient Health Record Identifier is a code (set of characters) used to uniquely
identify a patient within a health register or a HEALTH RECORDS SYSTEM, e.g.
PAS.

Field Name: UNITNUM
Field Type: Characters
Field Length: 14

Notes for Users:
The CHI number should always be used to identify a patient if available. However,
health record identifiers, such as hospital numbers in patient administration systems
(PAS), may be used locally until universal implementation of CHI has been achieved.

Codes and Values: N/A

Related Data Items: Location of Diagnosis

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 8
CHI Number
Main Source of Data Item Standard: Scottish Executive Health Department.

Definition:
The Community Health Index (CHI) is a population register, which is used in
Scotland for health care purposes. The CHI number uniquely identifies a person on
the index.

Field Name: CHINUM
Field Type: Characters
Field Length: 10

Notes for Users:
The Community Health Index (CHI) is a computer based population index whose
main function at present is to support primary care services. CHI contains details of
all Scottish residents registered with a General Practitioner and was originally
envisaged and implemented as a population-based index to help assess the success
of immunisation and screening programmes. It is therefore closely integrated with
systems for child health, cervical cytology and breast screening call and recall…It is
intended that this number, the Scottish equivalent of the new NHS number in
England and Wales, should become the Unique Patient Identifier throughout the
NHS in Scotland.
From Designed to Care - Scottish Office

The CHI number is a unique numeric identifier, allocated to each patient on first
registration with the system. The CHI number is a 10-character code consisting of
the 6-digit date of birth (DDMMYY), two digits, a 9th digit which is always even for
females and odd for males and an arithmetical check digit.
(ISD, Information Services, NHS National Services Scotland)

The CHI number should always be used to identify a patient. However, Health record
identifiers, such as hospital numbers in Patient Administration Systems (PAS), may
be used locally, in conjunction with the CHI number or in the absence of the CHI
number, to track patients and their records.

Although there may be no number when a patient presents for treatment, there must
be an allocation at some point in the episode of care as CHI is mandatory on all
clinical communications.

Non-Scottish patients and other temporary residents can have a CHI number
allocated if required but it is envisaged that future development may allow the
identifying number used in other UK countries to be used in Scotland.

Codes and values: N/A

Related Data Items: Date of Birth, Person Sex at Birth.

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 9
Section 2: Referral Details and Hospital Clinicians




     National Data Definitions for National Minimum Core Data Set for Lung Cancers
                     Developed by ISD Scotland, 2010 Version 2.1


                                          Page 10
Cancer Registration Incidence Date {Cancer}
Main Source of Data Item Standard: Cancer Registration (New Data definitions for
Socrates August 1999 Version 8.0 taken from the International Agency for Research
on Cancer (IARC) Cancer Registration Principles and Methods.

Definition:
Incidence date is the date that the cancer in question becomes formally known to
NHS Scotland.

Field Name: INCDATE
Field Type: (DD/MM/CCYY).
Field Length: 10

Notes for Users:
From Cancer Registration Definitions: Previously known as Date Treatment
Commenced.

For patients seen as outpatients and/or day cases and/or inpatients (other than long
stay or residential), it is the earliest available date from the following: Date of first
consultation as an outpatient. Date of admission to hospital. Date of first pathology
report confirming diagnosis. Date of hospital-initiated treatment. If none of the
above dates apply or can be established, the date of diagnosis (or best estimate)
should be used.

For long stay or residential patients, or patients receiving care at home, it is the date
of diagnosis (or best estimate).

For death certificate only cases (when follow-up attempts have been unsuccessful),
and for cases first diagnosed at autopsy (unsuspected during life), it is the date of
death.

Death certificate only cases are not included.

Codes and values: N/A

Related Data Items: N/A.

Notes by Users:




                                       Page revised 02/09/2010




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 11
Date of Cancer Referral
Main Source of Data Item Standard: The National Cancer Datasets developed by
the Cancer Networks supported by ISD from SEHD guidance issued 13 April 2005.

Definition:
Date of cancer referral is the date on which a referral is made by a primary care or
hospital clinician for symptoms that lead to a diagnosis of cancer.

Field Name: REFDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Noted for Users:
This is the date on the referral letter (if there are a number of dates record the date
the letter was typed) or fax message, or of the telephone call or e-mail and may be
the same date as the date on which the referral is received or earlier. If there is not
a referral correspondence, the date documented in the case notes should be
recorded.

If the patient is referred by another hospital clinician while being investigated for a
condition unrelated to their cancer (incidental finding), the date the patient was
referred for investigation of their cancer should be recorded.

For patients where the cancer was detected at a review clinic for pre-cancerous
conditions or an existing cancer, or at a cancer genetic clinic, the date the decision
was made to refer for further investigation of the cancer should be recorded.

For patients referred from screening the date the patient is first referred to a hospital
clinician for investigation of their cancer should be recorded. This may take place at
a screening centre or a hospital.

If a patient is referred from primary care but is admitted as an emergency before the
clinic date, record date of referral as the original referral date. If a patient has not
been referred previously for investigation of the cancer record the date the patient
presents to A&E or Acute Admissions, (self or GP referral).

If the exact date is not documented, record as 09/09/0909.

Date of referral may be after the date of diagnosis e.g. where the GP has excised
the tumour for melanoma.

Codes and values: N/A

Related data item: Source of Cancer Referral, Urgency of Cancer Referral.

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 12
Date Referral Received
Main Source of Data Item Standard: The National Audit Cancer Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
Date referral received is the date on which a healthcare service receives a referral.

Field Name: REFRECDATE
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
This may be the same as the date of referral or later. Also known as Referral
Received Date.

Definitions and Codes Manual, 6th Update, April 2002

For inter consultant referrals there may not always be a formal letter or
referral/telephone call. In which case the date of the original clinic where the
decision was made to refer to another consultant will be used as the date referral
received.

If the exact date is not documented, record as 09/09/0909.

Codes and Values: N/A

Related Data Items: Date of Cancer Referral

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 13
Source of Cancer Referral
Main Source of Data Item Standard:       The    National                          Cancer    Datasets
developed by the Cancer Networks supported by ISD.

Definition:
This denotes the route by which the patient was referred for investigation of signs or
symptoms that lead to a diagnosis of cancer.

Field Name: MREFER
Field Type: Characters
Field Length: 2

Notes for Users:
Patients may be referred by a general or dental practitioner to a clinic if the patient
presents with symptoms requiring further investigation which lead to a diagnosis of
cancer. A general practitioner is a registered practitioner who provides general
medical services to the community in partnership with other GPs or on a single-
handed basis. Patients presenting at A&E or acute admissions are often referred by
their general practitioner (and may already have an outstanding primary care referral
for cancer) so should be recorded under (code 8). Patients without a previous GP
referral should be coded as 6 (self referral) or 7 (GP referral).
After attending for routine screening in a Screening Programme a patient may be
referred for further investigation, 2 (screening service).
Some patients may be attending or referred to hospital for investigation or treatment
of a condition unrelated to their cancer and a tumour is diagnosed, 3 (incidental
finding).
Patients may attend an outpatient cancer clinic as they are being followed up for
benign disease or a previous cancer of the same site as diagnosed (4 review clinic)
or because of a strong family history of cancer (5 genetic clinic).
13 (Other) includes following a domiciliary visit by a hospital clinician.

Codes and Values:
Code        Value
   01       Primary care clinician (GP, Nurse practitioner)
   02       Screening service
   03       Incidental finding
   04       Review clinic
   05       Cancer genetic clinic
   06       Self-referral to A&E
   07       GP referral directly to hospital (A&E or other)
   08       Previous GP referral but subsequently admitted to hospital (A & E or other)
   09       Not recorded
   11       Primary care clinician (Dental)
   12       Referral from private healthcare
   13       Other

Related data item: Date of Cancer Referral, Urgency of Cancer Referral.
Notes by Users:

            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 14
Urgency of Cancer Referral
Main Source of Data Item Standard: ISD Definitions and Codes Manual, 6th
Update, April 2002 and SEHD guidance issued 13 April 2005.

Definition:
This denotes the urgency of referral for investigation of cancer as assigned by the
referring primary care clinician.

Field Name: URGENCYREF
Field Type: Characters
Field Length: 2

Notes for Users: Outpatient referral category is the classification of an outpatient
referral into urgent, soon and routine as perceived by the source of referral.

   •   Urgent - for clinical reasons, a patient requires an appointment at the earliest
       possible opportunity.

   This includes patients referred by a primary care clinician to where a risk based
   triage system is formally in place and the patient is subsequently categorised as
   high risk or urgent.

   •   Routine - a patient requires the next available routine appointment.

Emergency referrals should be classed as urgent. This includes self-referral to A &
E or Acute Admissions.

If a primary care clinician has not referred a patient then code as inapplicable.

If a patient is referred from primary care but is admitted as an emergency before the
clinic date, record urgency of referral as denoted by the referring primary care
clinician at the time of the original referral

Codes and Values:
 Code         Value
 01           Urgent
 03           Routine
 09           Not recorded
 10           Inapplicable

Related data item: Source of Cancer Referral, Date of Cancer Referral.

Notes by Users:




                                       Page revised 02/09/2010




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 15
Clinician 1-4
Main Source of Data Item Standard: The National Audit Cancer Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
Clinicians are consultants responsible for the management and care of a patient at a
given time.

Field Name: CLINAM 1-4
Field Type: Character
Field Length: 20

Notes for Users:
The data set allows for the full name of up to four hospital consultants to be
recorded. Record, in chronological sequence, the first four consultants seeing the
patient for their diagnosis and primary treatment. This also applies to those patients
where diagnosis is an incidental finding. Clinician 1 should be the first contact with a
secondary health care consultant that started the referral pathway leading to the
definitive diagnosis and subsequent treatment.

The surname and forename of each clinician should be recorded to distinguish
between consultants with common surnames. If there are two consultants with the
same forename and surname, the specialty of consultant will be required. If the
patient is seen by a member of the consultant’s junior staff, record the name of the
consultant in charge of the patient. If the patient is seen by a clinician who is
working as a locum, record only that the clinician is a locum consultant.

Clinicians names should be stored in databases as General Medical Council (GMC)
number.

If a clinicians name is not recorded code enter '9999'. If the patient does not see
clinician 2, 3 or 4 code as inapplicable (1010).

Codes and Values: N/A

Related Data Items: Specialty of Clinician 1-4, Date First Seeing Clinician 1-4

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 16
Specialty of Clinician 1-4
Main Source of Data Item Standard: The National Audit Cancer Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The speciality of the clinician is the specialty in which he/she is formally recognised
and contracted to work. A clinician may be formally recognised and contracted to
work in more than one speciality; in these cases one speciality is recognised as the
main one.

Field Name: CLINSPEC 1-4
Field Type: Character
Field Length: 3

Notes for Users:
The specialty of up to four clinicians can be recorded. The first specialty should
relate to the first hospital clinician recorded in the clinician field, the second for the
second clinician etc. If the clinician is a locum the specialty should still be recorded.

If the patient does not see clinician 2, 3 or 4 code as inapplicable (96).

Codes and Values:
Code        Value
A1          General Medicine
A2          Cardiology
A3          Clinical Genetics
A5          Clin Pharm. & Therap.
A6          Communicable Diseases
A7          Dermatology
A8          Endocrine & Diabetes
A9          Gastroenterology
AA          Genito-Urinary Medicine
AB          Geriatric Medicine
AC          Homoepathy
AD          Medical Oncology
AF          Medical Paediatrics
AFA         Community Child Health
AG          Nephrology
AH          Neurology
AK          Occupational Health
AM          Palliative Medicine
AN          Public Health Medicine
AP          Rehabilitation Med.
AQ          Respiratory Medicine
AR          Rheumatology
C1          General Surgery
C2          Accident & Emergency
C3          Anaesthetics
C4          Cardiothoracic Surgery

            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 17
C5         ENT Surgery
C6         Neurosurgery
C7         Ophthalmology
C8         Orthopaedic Surgery
C9         Plastic Surgery
CA         Surgical Paediatrics
CB         Urology
D1         Community Dentistry
D3         Oral Surgery
D4         Oral Medicine
D5         Orthodontics
D6         Restorative Dentistry
D7         Community Dental Health
D8         Paediatric Dentistry
F1         Obstetrics & Gynaecology
F1A        Well Woman Service
F1B        Family Planning Service
G1         General Psychiatry
G1A        Community Psychiatry
G2         Child & Adolescent Psych
G3         Forensic Psychiatry
G4         Old Age Psychiatry
G5         Mental Handicap
G6         Psychotherapy
H1         Diagnostic Radiology
H1A        Breast Screening Service
H2         Radiotherapy
H3         Nuclear Medicine
J1         Pathology
J2         Blood Transfusion
J3         Clinical Chemistry
J4         Haematology
J5         Immunology
J6         Microbiology
J7         Virology
96         Not applicable
99         Not recorded

Related Data Items: Clinician 1-4

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 18
Date of First Seeing Clinician 1-4 {Lung Cancer}

Main Source of Data Item Standard: The National Audit Cancer Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
Date of first seeing clinician is the date on which a consultant clinician (or one of his
team) first sees a patient for investigation or management of lung cancer following
referral from primary or secondary healthcare.

Field Name: FCLINDATE 1-4
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
Dates for up to four clinicians can be recorded. The first date should relate to the first
clinician in the first specialty, the second for the second clinician etc.

If the exact date is not documented, record as 09/09/0909.

The patient may not see clinician 2, 3 or 4. In this case record as 10/10/1010
(inapplicable) where appropriate.

Codes and Values: N/A

Related Data Items: Clinician 1-4

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 19
Date Discussed by Care Team (Pre-treatment)

Common Name(s): Date discussed by multidisciplinary team {Cancer}.

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes the date the care team meeting was held to discuss the management
of the patient's care

Field Name: MDTDATE
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
A cancer multidisciplinary care team may include surgeons, oncologists, radiologists,
pathologists, nurses, speech language therapists, physiotherapists and others
relevant to the treatment of a specific cancer. The team meets on a regular basis to
discuss optimal patient management. Documentation of the discussion should be
included in the case-note or other formal documentation.

This item may occur more than once throughout a patient’s record.

The first MDT meeting date will be recorded.

If the date of the MDT meeting is unknown record as 09/09/0909 or if the patient has
not been discussed by the MDT, record as inapplicable 10/10/1010.

Codes and Values: N/A

Related Data Items:

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 20
Care Team Meeting Actions Recorded (Pre-treatment)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
A record of whether the care team meeting actions were recorded at the MDT
meeting.

Field Name: MDTACTION
Field Type: Character
Field Length: 2

Notes for Users:
None.

Codes and Values:
Code    Value
00      No
01      Yes
96      Inapplicable
99      Not known

Related Data Items: Date Discussed by Care Team (Pre-treatment)

Notes by Users:




          National Data Definitions for National Minimum Core Data Set for Lung Cancers
                          Developed by ISD Scotland, 2010 Version 2.1


                                               Page 21
Reason Not Discussed by Care Team (Pre-treatment)
Common Name(s): Reason not discussed by multidisciplinary team {Cancer}.

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The reason the proposed management and treatment of the patient/client was not
discussed by the care/multidisciplinary team.

Field Name: REASONNOMDT
Field Type: Characters
Field Length: 2

Notes for Users:
Some issues will not need to be reviewed by an MDT, some will be reviewed once
only and others may require a weekly review on an ongoing basis.

Users should augment code ‘98 – Other (specify)’ with a free text field for recording
other values of this item.

Codes and Values:
 Code        Value
 00          No reason given
 01          Not indicated
 02          Clinical decision
 03          Care team not available
 04          Patient declined
 05          Patient died
 96          Not applicable
 98          Other, specify
 99          Not known

Related Data Items:

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 22
Section 3: Diagnostic Procedures, Staging and
                 Assessment




   National Data Definitions for National Minimum Core Data Set for Lung Cancers
                   Developed by ISD Scotland, 2010 Version 2.1


                                        Page 23
Date of Chest x-Ray

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date of the first abnormal x-ray which suggests a diagnosis of lung cancer
or mesothelioma.

Field Name: XDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
This may happen in primary or secondary care.

If the exact date of the chest x- ray is not documented, record as 09/09/0909.

If no chest x-ray was performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 24
Date of CT/MRI Thorax

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes the date that the CT/MRI of the thorax was performed for staging and
assessment.

Field Name: CTHORAXDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the patient has more than one CT/MRI of thorax the date of the first procedure is
recorded.

If the exact date of the CT/MRI thorax is not documented, record as 09/09/0909.

If CT/MRI thorax was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 25
Date of Integrated FDG-PET/CT (PET/CT) Scan

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes the date that the integrated FDG-PET/CT (PET/CT) scan was
performed for staging and assessment.

Field Name: PETDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the patient has more than one PET/CT scan the date of the first procedure is
recorded.

If the exact date of the PET/CT Scan is not documented, record as 09/09/0909.

If PET/CT scan was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 26
Date of CT/MRI Brain

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes the date that the CT/MRI of brain was performed for staging and
assessment of metastatic spread.

Field Name: CTBRAINDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the patient has more than one CT/MRI of brain the date of the first procedure is
recorded.

If the exact date of the brain CT/MRI scan is not documented, record as 09/09/0909.

If CT/MRI of the brain was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 27
Date of Bronchoscopy {Lung Cancer}

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The date of bronchoscopy is the date the procedure was performed for the purposes
of investigating a possible diagnosis of lung cancer.

Field Name: BDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the patient has more than one bronchoscopy the date of the first procedure is
recorded.

If the exact date of the bronchoscopy is not documented, record as 09/09/0909.

If bronchoscopy was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 28
Date of Endobronchial Ultrasound (EBUS)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The date of EBUS is the date the procedure was performed for the purposes of
investigating a possible diagnosis of lung cancer.

Field Name: EBUSDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the patient has more than one EBUS the date of the first procedure is recorded.

If the exact date of the EBUS is not documented, record as 09/09/0909.

If EBUS was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 29
Date of Image Guided Biopsy or FNA of Lung

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The date the image guided biopsy or FNA was performed for the purposes of
investigating a possible diagnosis of cancer.

Field Name: IMGUIDDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the patient has more than one image guided biopsy or FNA the date of the first
procedure is recorded.

If the exact date is not documented, record as 09/09/0909.

If no image guided biopsy or FNA was not performed, record as 10/10/1010
(inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




                                   Page revised 02/09/2010




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 30
Other Tissue Diagnosis Specimen Site

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
A record of the type of any other biopsy performed that led to diagnosis.

Field Name: OTHSPECSITE
Field Type: Character
Field Length: 3

Notes for Users:
Users may wish to augment code ‘98 – Other (specify)’ with a free text field for
recording other values of this item.

Codes and Values:
  Code    Value                                  Sub-        Sub-value
                                                 code
    01    Adrenal gland
    02    Liver
    03    Skin
    04    Bone
    05    Pleura
                                                 A           Pleural Fluid
                                                 B           Pleural Biopsy
    06    Supraclavicular Nodes
    07    Lymph Nodes
    08    Mediastinum
    96    Not applicable
    98    Other, specify
    99    Not recorded

Related Data Items: Date of Other Tissue Diagnosis

Notes by Users:




              National Data Definitions for National Minimum Core Data Set for Lung Cancers
                              Developed by ISD Scotland, 2010 Version 2.1


                                                   Page 31
Date of Other Tissue Diagnosis

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The date any other biopsy or FNA, was performed.

Field Name: OTHDDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
This refers to page 31 Other tissue diagnosis specimen site’.

If the exact date is not documented, record as 09/09/0909.

If no other biopsy was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: Other Tissue Diagnosis Specimen Site

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 32
Laterality {Cancer}
Main Source of Data Item Standard: The National Cancer Datasets developed by
the Cancer Networks supported by ISD and the Scottish Cancer Registry Guidelines,
Fourth Edition, 2001.

Definition: The side or laterality (i.e. left or right) of the body in which the tumour is
located.

Field Name: SIDE
Field Type: Characters
Field Length: 2

Notes for Users:
This item should be recorded for all paired organs and may be applicable for other
tumours e.g. skin, tonsil.

Codes and values:
Code    Value                  Explanatory Notes
01      Right
02      Left
03      Bilateral
04      Midline           Central tumours i.e. those whose point of origin
                          cannot be assigned to left or right are regarded as
                          midline. For lymph nodes, station 7 is the only
                          central one. If no station or laterality is indicated,
                          record as 'Not known'.
96         Not applicable e.g. Non-paired organs
99         Not known      Includes not recorded

Related Data Items:

Notes by Users:




                                    Page revised 02/09/2010




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 33
Origin of Tumour

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The origin of the primary tumour as detected clinically (including imaging).

Field Name: ORIGIN
Field Type: Characters
Field Length: 2


Notes for Users:
None.

Codes and Values:
Code    Value

   01     Lung Cancer
   02     Mesothelioma

Related Data Items: N/A

Notes by Users:




                                   Page inserted 02/09/2010




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 34
Site of Tumour
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The anatomical site of origin of the primary tumour

Field Name: SITE
Field Type: Characters
Field Length: 5

Notes for Users:
Users should augment code ‘98 – Other (specify)’ with a free text field for recording
other values of this item.

Codes and Values:
ICD-O(3) Description                            Explanatory notes
Code
  C34.0 Main Bronchus                           Includes Carina; Holus of lung.
  C34.1 Upper lobe, lung                        Includes Lingual of lung; Upper lobe
                                                bronchus
  C34.2   Middle lobe, lung                     Includes Middle lobe, bronchus.

  C34.3   Lower lobe, lung                      Includes Lower lobe, bronchus
  C34.8   Overlapping lesion of lung
  C34.9   Lung                                  Includes Bronchus, NOS; Bronchiole;
                                                Bronchogenic; Pulmonary NOS.
  C33.9   Trachea
  C38.3   Mediastinum
  C38.0   Pericardium
  C38.4   Pleura
  C38.8   Overlapping lesion of heart,
          mediastinum and pleura
  C48.2   Peritoneum*                           NOS, Includes Peritoneal Cavity.

  C67.7   Tunica Vaginalis*
   98     Other, specify
   99     Not recorded

Related Data Items: Origin of Tumour

Notes by Users:


   * Mesothelioma only.

                                   Page revised 02/09/2010



           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 35
Date of Diagnosis {Cancer}
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The date on which the best evidence in support of a diagnosis of cancer was made,
whether by histology, cytology, immunology, cytogenetics or clinical (including
radiological) methods.

Field Name: DIAGDATE
Field Type: Date (DD/MM/CCYY)
Field length: 10

Notes for Users:
If a patient was provisionally diagnosed at one hospital but transferred to another for
confirmation of the diagnosis only e.g. biopsy, then returns to the original hospital,
the date of the first provisional diagnosis should be recorded as the date of
diagnosis.

The date of diagnosis may also be the same as the date histo/cytological specimen
taken.

The date recorded is the date the procedure was performed, not the date the report
was issued.

If the exact date is not documented, record as 09/09/0909.

Codes and values: N/A

Related Data Items: Most Valid Basis of Diagnosis

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 36
Most Valid Basis of Diagnosis {Cancer}
Main Source of Data Item Standard: International Agency for Research on Cancer
(IARC) and Scottish Cancer Registry Guidelines, Fourth Edition, 2001.

Definition:
The best evidence in support of the diagnosis of cancer.

Field Name: VALID
Field Type: Characters
Field Length: 2

Notes for Users:
The conclusion of a diagnosis of cancer may be based on one or several
procedures; clinical findings or as a report on the death certificate. Histological
confirmation is considered as the most valid basis of diagnosis.

The methods of diagnosis are listed in essentially ascending order of validity,
microscopic methods having greater validity than non-microscopic methods.

NB: With the emergence of molecular markers etc., there are plans to review the
definition of this variable in the context of updating the IARC monograph, Cancer
Registration Principles and Methods.

For the purposes of national lung cancer audit, tumour specific markers and death
certificate only do not apply.

Codes and Values:
 Code Value                                      Explanatory Notes
 01      Clinical only                           The diagnosis is based solely on clinical findings (history
                                                 and/or physical examination). This is made before death but
                                                 without the benefit of the following:
 02      Clinical investigation                  The diagnosis is supported by investigations such as x-ray,
                                                 CT scan, ultrasound etc.
 03      Exploratory                             The tumour has been visualised or palpated but there is no
         surgery/endoscopy/autopsy               confirmatory microscopic evidence
         (without concurrent or
         previous histology)
 04      Tumour specific markers                 The diagnosis is supported by specific tests
         (biochemical/immunological
         tests)
 05      Cytology                                The diagnosis is supported by cytology (the examination of
                                                 cells whether from a primary or secondary site).
 06      Histology of metastasis                 The diagnosis is based on the histology of a metastasis
                                                 (secondary deposit), e.g. resulting from a lymph node biopsy
 07      Histology of primary                    The diagnosis is based on the histology of the primary either
                                                 resulting from a biopsy or from complete resection of the
                                                 tumour.
 08      Autopsy (with histology)                The diagnosis is based on the findings at autopsy supported
                                                 by concurrent or previous histology.
 10      Death Certificate only                  The only information available to the registry is from a death
                                                 certificate.
 99      Not known
Related Data Items: Date of Diagnosis
           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 37
Notes by Users:




          National Data Definitions for National Minimum Core Data Set for Lung Cancers
                          Developed by ISD Scotland, 2010 Version 2.1


                                               Page 38
Date of Mediastinoscopy

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date the mediastinoscopy was performed.

Field Name: MEDIASTDATE
Field Type: Date (DD/MM/CCYY)
Field length: 10

Notes for Users:
If the exact date is not documented, record as 09/09/0909.

If mediastinoscopy was not performed, record as 10/10/1010 (inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 39
Date of Thoracotomy/Thoracoscopy (VATS) (Pre-treatment)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date the thoracotomy/thoracoscopy was performed.

Field Name: THORADATE
Field Type: Date (DD/MM/CCYY)
Field length: 10

Notes for Users:
If the exact date is not documented, record as 09/09/0909.

If thoracotomy/thoracoscopy            was      not       performed,      record      as   10/10/1010
(inapplicable).

Codes and Values: N/A

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 40
TNM Tumour Classification (Clinical)
Common name: Clinical TNM Tumour Classification (Lung Cancer)

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The size and extent of the tumour as determined by pre-treatment investigations (not
pathological), coded according to the official TNM Classification (TNM Classification
of Malignant Tumours, Seventh Edition, 2009).

Field Name: TLUNG
Field Type: Characters
Field length: 3

Notes for Users:
Clinical TNM is derived from all the clinical, radiological and biochemical results prior
to treatment. The TNM system is base on the assessment of three components (T
tumour, N node and M metastases) and the addition of numbers after the letter
components to indicate the extent of the malignant disease.

In the case of multiple simultaneous tumours in one or two lungs, the tumour with the
highest T category should be used for classification.

This is the clinical TNM as at the time of the MDT meeting where the decision to
treat was made.

Codes and Values:
Code Value                   Sub- Sub-value                 Explanatory Notes
                             code
00      TNM                                                 No evidence of primary tumour
        Classification T0

01      TNM                                                 Carcinoma in situ (CIS)
        Classification Tis

02      TNM                  Tumour up to ≤ 3cm, surrounded by lung or visceral pleura,
        Classification T1    without bronchoscopic evidence of invasion more proximal
                             than the lobar bronchus (i.e. not the main bronchus).
                             A        ≤ 2cm                 The uncommon superficial spreading
                                                            tumour of any size with its invading
                                                            component limited to the bronchial
                                                            wall, which may extend proximal to
                                                            the main bronchus, is also classified
                                                            as T1a.
                             B        > 2cm – 3cm

03      TNM                  Tumour > 3cm to ≤ 7cm, Involves Main bronchus ≥ 2cm
        Classification T2    distal to the carina, or invades visceral pleura, or associated
                             with atelectasis or obstructive pneumonia that extends to the
                             hilar region but does not involve the entire lung.

            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 41
                            A        > 3cm – 5cm           T2 tumours with above features are
                                                           classified as T2a if 5cm of less, or if
                                                           size cannot be determined.
                            B        > 5cm – 7cm           T2 tumours with above features are
                                                           classified as T2b if greater than 5cm
                                                           but not larger than 7cm.
04     TNM                  Tumour > 7cm; or Tumour of any size that directly invades any
       Classification T3    of the following: chest wall (including superior sulcus tumours),
                            diaphragm, phrenic nerve, mediastinal pleura, parietal
                            pericardium; or tumour in the main bronchus < 2cm distal to
                            the carina but without the involvement of the carina; or
                            associated atelectasis or obstructive pneumonitis of the entire
                            lung or separate tumour nodule(s) in the same lobe as the
05     TNM                    i
                            Tumour of any size that invades any of the following:
       Classification T4    Mediastinum, heart, great vessels, trachea, recurrent laryngeal
                            nerve, oesophagus, vertebral body; carina, separate tumour
                            nodule(s) in a different ipsilateral lobe to that of the primary.
06     TNM                                              Primary tumour cannot be assessed
       Classification TX
96     Not applicable
99     Not known

Related data items:
TNM Nodal Classification (Clinical) (Lung Cancer)
TNM Metastases Classification (Clinical) (Lung Cancer)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 42
TNM Nodal Classification (Clinical)
Common name: Clinical TNM Nodal Classification (Lung Cancer).

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The extent of regional lymph node metastases as determined by pre-treatment
investigations (not pathological), coded according to the official TNM Classification
(TNM Classification of Malignant Tumours, Seventh Edition, 2009).

Field Name: NLUNG
Field Type: Characters
Field length: 2

Notes for Users:
This is the clinical TNM as at the time of the MDT meeting where the decision to
treat was made.

Codes and Values:
Code Value                         Explanatory Notes
00     TNM Classification N0 No regional lymph nodes metastasis.

01     TNM Classification N1 Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph
                             nodes and intrapulmonary nodes, including involvement by direct
                             extension.
02     TNM Classification N2 Metastasis in ipsilateral mediastinal and/or subcarinal lymph
                             node(s).
03     TNM Classification N3 Metastasis in contralateral mediastinal, contralateral hilar,
                             ipsilateral or contralateral scalene, or supraclavicular lymph
                             node(s).
04     TNM Classification NX Regional lymph nodes cannot be assessed (e.g. previously
                             removed).
96     Not applicable
99     Not known

Related Data items:
TNM Tumour Classification (Clinical) (Lung Cancer)
TNM Metastases Classification (Clinical) (Lung Cancer)


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 43
TNM Metastases Classification (Clinical)
Common name: Clinical TNM Metastases Classification (Lung Cancer).

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The extent of metastatic spread of the tumour as determined by pre-treatment
investigations (not pathological), coded according to the official TNM Classification
(TNM Classification of Malignant Tumours, Seventh Edition, 2009).

Field Name: MLUNG
Field Type: Characters
Field length: 3

Notes for Users:
This is the clinical TNM as at the time of the MDT meeting where the decision to
treat was made.

Codes and Values:
Code   Value                 Sub-      Sub-value                Explanatory Notes
                             code
00     TNM                                                      No distant metastasis.
       Classification M0

01     TNM               Distant Metastasis
       Classification M1

                             A         Separate tumour          Most pleural (pericardial) effusions with lung
                                       nodule(s) in a           cancer are due to tumour. In a few patients,
                                       contralateral lobe;      multiple microscopical examinations of pleural
                                       tumour with pleural      (pericardial) fluid are negative for tumour, and the
                                       nodules or               fluid is non-bloody and is not an exudate. Where
                                       malignant pleural or     these elements and clinical judgement dictate that
                                       pericardial effusion.    the effusion is not related to the tumour, the
                                                                effusion should be excluded as a staging element
                                                                and the patient should be classified as M0.

                             B         Distant metastasis
96     Not applicable
99     Not known


Related data items:
TNM Nodal Classification (Clinical) (Lung Cancer)
TNM Tumour Classification (Clinical) (Lung Cancer)

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 44
Synchronous Primary Tumours

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes whether or not synchronous primary tumours are present.

Field Name: MULTIPLE
Field Type: Characters
Field length: 3

Notes for Users:
This refers to the presence of synchronous primary tumours which may be in the
same lung (ipsilateral) or involving both sides (Bilateral).

Record the presence or absence of synchronous tumours.

Codes and Values:
  Code    Description           Sub-      Sub-value
                                code
   00     No
   01     Yes
                                A         Ipsilateral
                                B         Bilateral
   99     Not known


Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 45
TNM Tumour Classification (Clinical) (Pleural Mesothelioma)
Common name: Clinical TNM Tumour Classification (Pleural Mesothelioma)

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The size and extent of the tumour as determined by pre-treatment investigations (not
pathological), coded according to the official TNM Classification (TNM Classification
of Malignant Tumours, Seventh Edition, UICC, 2009).

Field Name: TMESO
Field Type: Characters
Field length: 3

Notes for Users:
There is no staging of peritoneal mesothelioma.

This is the clinical TNM as at the time of the MDT meeting where the decision to
treat was made.

Codes and values:
 Code Value                            Sub- Sub-value                             Explanatory Notes
                                       code
 00     TNM Classification T0                                                     No evidence   of    primary
                                                                                  tumour
 01     TNM Classification T1          A        Tumour            involves        .
                                                ipsilateral        parietal
                                                (mediastinal,
                                                diaphragmatic) pleura.
                                                 No     involvement      of
                                                visceral pleura
                                       B        Tumour            involves .
                                                ipsilateral        parietal
                                                (mediastinal,
                                                diaphragmatic)      pleura
                                                with Focal involvement
                                                of visceral pleura
 02     TNM Classification T2          Tumour involves any ipsilateral pleural surfaces, with at least one
                                       of the following:
                                            • Confluent visceral pleural tumour (including fissure).
                                            • Invasion of diaphragmatic muscle.
                                            • Invasion of lung parenchyma.
 03     TNM Classification T3*         Tumour involves any ipsilateral pleural surfaces, with at least one
                                       of the following:
                                            • Invasion of endothoracic fascia.
                                            • Invasion into mediastinal fat.
                                            • Solitary focus of tumour invading soft tissues of the chest
                                                wall.
                                            • Non-transmural involvement of the pericardium.
 04     TNM Classification T4†         Tumour involves any ipsilateral pleural surfaces, with at least one
                                       of the following:
                                            • Diffuse or multifocal invasion of soft tissues of chest wall.
           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 46
                                            •    Any involvement of rib.
                                            •    Invasion through diaphragm to peritoneum.
                                            •    Invasion of any mediastinal organ(s).
                                            •    Direct extension to contralateral pleura.
                                            •    Invasion in to the spine.
                                            •    Extension to internal surface of pericardium.
                                            •    Pericardial effusion with positive cytology.
                                            •    Invasion of myocardium.
                                            •    Invasion of brachial plexus.
 05     TNM Classification TX                                                 Primary tumour cannot be
                                                                              assessed
 96     Not applicable                                                        Diagnosis        is   not
                                                                              mesothelioma.
 99     Not known

Related data items:
TNM Nodal Classification (Clinical) (Pleural Mesothelioma)
TNM Metastases Classification (Clinical) (Pleural Mesothelioma)



Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 47
TNM Nodal Classification (Clinical) (Pleural Mesothelioma)
Common name: Clinical TNM Nodal Classification (Pleural Mesothelioma).

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The extent of regional lymph node metastases as determined by pre-treatment
investigations (not pathological), coded according to the official TNM Classification
(TNM Classification of Malignant Tumours, Seventh Edition, UICC, 2009).

Field Name: NMESO
Field Type: Characters
Field length: 2

Notes for Users:
There is no staging of peritoneal mesothelioma.

This is the clinical TNM as at the time of the MDT meeting where the decision to
treat was made.

Codes and Values:
Code Value                            Explanatory Notes
00      TNM Classification N0         No regional lymph nodes metastasis.
01      TNM Classification N1         Metastasis in ipsilateral bronchopulmonary and/or hilar
                                      lymph node(s).
02      TNM Classification N2         Metastasis in subcarinal lymph node(s) and/or internal
                                      mammary or mediastinal lymph node(s).
03      TNM Classification N3         Metastasis in contralateral mediastinal, internal
                                      mammary or hilar node(s) and /or ipsilateral or
                                      contralateral supraclavicular or scalene lymph node(s).
04      TNM Classification NX         Regional lymph nodes cannot be assessed (e.g.
                                      previously removed).
96      Not applicable                Diagnosis is not mesothelioma.
99      Not known

Related Data items:
TNM Tumour Classification (Clinical) (Pleural Mesothelioma)
TNM Metastases Classification (Clinical) (Pleural Mesothelioma)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 48
TNM Metastases Classification (Clinical) (Pleural
Mesothelioma)
Common name: Clinical TNM Metastases Classification (Pleural Mesothelioma).

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The extent of metastatic spread of the tumour as determined by pre-treatment
investigations (not pathological), coded according to the official TNM Classification
(TNM Classification of Malignant Tumours, Sixth Edition, 2002).

Field Name: MMESO
Field Type: Characters
Field length: 2

Notes for Users:
There is no staging of peritoneal mesothelioma.

This is the clinical TNM as at the time of the MDT meeting where the decision to
treat was made.

Codes and values:
 Code Value                                Explanatory Notes
 00     TNM Classification M0              No distant metastasis.
 01     TNM Classification M1              Distant metastasis.
 96     Not applicable                     Diagnosis is not mesothelioma.
 99     Not known


Related data items:
TNM Nodal Classification (Clinical) (Pleural Mesothelioma)
TNM Tumour Classification (Clinical) (Pleural Mesothelioma)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 49
WHO/ ECOG Performance Status
Main Source of Data Item Standard: WHO (World Health Organisation) and ECOG
(Eastern Cooperative Oncology Group)

Definition:
An overall assessment of the functional/physical performance of the patient.

Field Name: PSTATUS
Field Type: Character
Field length: 1

Notes for Users:
The WHO/ECOG performance status is a grade on a five point scale (range 0 to 4)
at the time of investigation in which '0' denotes normal activity and '4' a patient who
is 100% bedridden. If it is not documented do not deduce from other information and
record as 'Not known'.

This item may occur more than once throughout a patient’s record.

This field relates to pre-treatment performance status i.e. at the time of the MDT
closest to actual treatment.
If the performance status falls between two scores, record the higher value i.e. the
worst performance status.

Codes and values:
Code   Value
0      Fully active, able to carry on all pre-disease performance without restriction
1      Restricted in physically strenuous activity but ambulatory and able to carry out work
       of a light or sedentary nature, e.g. light housework, office work
2      Ambulatory and capable of self care but unable to carry out any work activities: up
       and about more than 50% of waking hours
3      Capable of only limited self care, confined to bed or chair more than 50% of waking
       hours
4      Completely disabled, cannot carry on any self care, totally confined to bed or chair

9      Not known

Related Data Items: N/A


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 50
Seen by Clinical Nurse Specialist {Lung Cancer /
Mesothelioma}
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
A record of whether or not a patient had the support of a clinical nurse specialist
during their journey for the investigation and management of their cancer.

Field Name: CNS
Field Type: Characters.
Field Length: 2

Notes for Users:
In this context a clinical nurse specialist is a nurse who has specific expertise in the
care and support of patients with cancer. Record as Yes if the nurse has supported
the patient through any of the different stages of their journey i.e. investigation,
staging, diagnosis and treatment.

Specialist palliative care and stoma nurses are excluded from this standard, as they
are separate data standards in themselves.

There are a number of clinical nurse specialist posts that are employed by Macmillan
throughout Scotland. These posts are often in hospital or the community. In
practice, the core components should be the same regardless of whether they are
NHS or Macmillan

Codes and Values:
Code    Value
00      No
01      Yes
02      Planned
99      Not known

Related Data Items: N/A

Notes by Users:




                                   Page inserted 02/09/2010




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 51
             Section 4: Pathology (Diagnostic)




Location Code {Cancer Pathology}
       National Data Definitions for National Minimum Core Data Set for Lung Cancers
                       Developed by ISD Scotland, 2010 Version 2.1


                                            Page 52
Common Name(s): Location, Location of Contact.

Main Source of Data Item Standard: Derived from SMR data standards.

Definition:
This is the reference number of any building or set of buildings where events
pertinent to NHS Scotland take place. Locations include hospitals, health centres,
GP surgeries, clinics, NHS board offices, nursing homes, schools and patient/client's
home.

Field Name: PATHLAB
Field Type: Characters
Field Length: 5

Further Information:
Each location has a location code, which is maintained jointly by ISD and General
Register Office (Scotland).http://www.show.scot.nhs.uk/smrfiles/information.html –
datafiles

Location must be viewed as an address and not a code. If any new locations arise
where NHS healthcare is delivered/administered, please ensure that the Reference
Files Team at ISD is informed using form LOC-NEW (which can be downloaded from
the website below) so that a new code may be issued as appropriate.
http://www.show.scot.nhs.uk/smrfiles

Information about location should be electronically stored, managed and transferred
using the relevant location code. IT systems should allow the recording and display
of locations on the user interface as the relevant location name and associated
address, etc.

Example s of codes are given below.

  Code                            Institution
A111H      CROSSHOUSE HOSPITAL
C418H      ROYAL ALEXANDRA HOSPITAL
F704H      VICTORIA HOSPITAL, KIRKCALDY
F705H      FORTH PARK HOSPITAL, KIRKCALDY
G107H      GLASGOW ROYAL INFIRMARY
G405H      SOUTHERN GENERAL HOSPITAL, GLASGOW
G412V      ROSS HALL HOSPITAL*
G516H      WESTERN INFIRMARY/GARTNAVEL GENERAL
H202H      RAIGMORE HOSPITAL
L106H      MONKLANDS HOSPITAL, AIRDRIE
L308H      WISHAW GENERAL HOSPITAL
L302H      HAIRMYRES HOSPITAL, EAST KILBRIDE
N101H      ABERDEEN ROYAL INFIRMARY
S116H      WESTERN GENERAL HOSPITAL, EDINBURGH
S124V      MURRAYFIELD HOSPITAL*
S314H      ROYAL INFIRMARY, EDINBURGH
T101H      NINEWELLS HOSPITAL
T202H      PERTH ROYAL INFIRMARY

           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 53
V201H       STIRLING ROYAL INFIRMARY
Y104H       DUMFRIES & GALLOWAY ROYAL INFIRMARY
X9999       NOT RECORDED
X1010       NOT APPLICABLE

* Private hospital.


Related Data Items: N/A

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 54
Date Histo/ Cytopathological Specimen Taken

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date the histo/ cytopathogical specimen was taken.

Field Name: PATHDATE
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
This could be a biopsy, cytology, or surgical excision specimen.

This item may occur more than once throughout a patient’s record.

This equates to date of histological diagnosis.

If the exact date is not documented, record as 09/09/0909.
If no specimen has been taken, record as inapplicable, 10/10/1010.


Codes and values: N/A

Related data items: N/A



Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 55
Histology/Cytology (Diagnostic/Pre-Surgery)
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition;
This is the microscopic examination of the specimen by a pathologist to determine
the presence of malignancy and the classification of the malignant tumour.

Field Name: HIST
Field Type: Characters
Field Length: 2

Notes for Users:
There may be more than one biopsy/histology report. If reports are close together
amalgamate findings from reports. If there is a discrepancy between reports of
sputum cytology and bronchoscopy specimen, take the report relating to
bronchoscopy as the definitive report.
The WHO Classification is intended primarily for use with surgically resected cases
and cannot be applied in full to small biopsy/cytology diagnosis. Consequently, a
proportion of cases on biopsy/cytology specimens will be reported as “non-small
cell carcinoma" (NSCLC), as this is as specific a diagnosis as may be possible on
the material available Allocation to tumour subtype or variant category is often not
possible on diagnostic samples.
If a report is no more specific than “malignant cells” and does not further classify the
tumour as carcinoma or other type of malignancy, the histology should be recorded
as "other malignancies". Findings reported as “carcinoma, NOS” should also be
recorded as "other malignancies".
If no histology/cytology is carried out, record as inapplicable as detailed below.

Pathology taken after a patient had initially refused further investigation or
whose initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code     Value                                     Explanatory Notes
11       Squamous                                  Includes all variants
12       Adenocarcinoma                            includes acinar, papillary, bronchiolo-alveolar, solid,
                                                   signet ring cell and mucus cell types or patterns

13       NSCLC, not otherwise specified            Includes large cell carcinoma and undifferentiated,
         (NOS)                                     pleomorphic, sarcomatoid or anaplastic carcinoma

14       Other specific non-small cell             includes salivary-type carcinomas and large cell
         carcinomas                                neuroendocrine carcinomas
21       Small cell carcinoma (SCLC)               includes formerly used terms oat cell, intermediate cell
                                                   type and combined SCLC/NSCLC cases

22       Carcinoid tumour              includes typical and atypical carcinoid
31       Combination of non-small cell includes adenosquamous carcinoma and other mixed
         components                    NSCLC-type cases


            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 56
41      Other malignancies (including Includes cases reported as ‘carcinoma, NOS’ and
        malignancy NOS)                 metastatic tumours
42      Mesothelioma Unspecified
43      Epithelioid Mesothelioma
44      Sarcomatoid/Spindle        Cell
        Mesothelioma
45      Biphasic Mesothelioma
8       Negative histology
9       Not recorded
10      Inapplicable    –   reason not
        documented
20      Inapplicable      –     documented


Related Data Items: Date Histo/ Cytopathological Specimen Taken.

Notes by Users:




          National Data Definitions for National Minimum Core Data Set for Lung Cancers
                          Developed by ISD Scotland, 2010 Version 2.1


                                               Page 57
Reason Histology/Cytology not Performed

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
An explanation for histology/cytology not having taken place.

Field Name: REASONNOHIST
Field Type: Characters
Field Length: 2

Notes for Users:
None.

Codes and Values:
  Code    Value                                           Explanatory notes
   01     Co-morbidity                                    Includes tumour related morbidity
   02     Would not alter management
   03     Failed attempt
   95     Patient declined
   96     Not applicable                                  e.g. Histology/cytology performed
   99     Not recorded

Related Data Items:

Notes by Users:



                                   Page revised 02/09/2010




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 58
Section 5: Surgery and Post-Resection Pathology




    National Data Definitions for National Minimum Core Data Set for Lung Cancers
                    Developed by ISD Scotland, 2010 Version 2.1


                                         Page 59
Type of First Cancer Treatment
Common name: Mode of first treatment

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes the first specific treatment modality administered to a patient.

Field Name: MODE1
Field Type: Characters.
Field length: 2

Notes for Users:
This field is included in the data standards to enable the accurate recording of
waiting times. For any particular modality it is the first treatment and not specifically
the definitive treatment i.e. this does not include purely diagnostic biopsies such as
incisional biopsies, needle biopsies or core biopsies. Some biopsies, such as
excisional biopsies and cone biopsies may be included as these may have some
therapeutic benefits i.e. the removal of the tumour.

Record patients as having ‘no active treatment’ if a decision was taken not to give
the patient treatment as part of their primary therapy (some patients that have ‘no
active treatment’ may subsequently have treatment when symptoms develop but this
is not primary therapy). No active treatment includes watchful waiting and
supportive care but not palliative chemotherapy and/or radiotherapy.

Dilatation without other treatment is not considered as active treatment.

Steroids, drainage of pleural effusions etc should not be recorded as first
treatment if more substantive treatment such as radiotherapy, chemotherapy
or surgery is given. If no further treatment is given, then record as supportive
care.

Codes and values:
Code Description                                           Explanatory notes
01      Surgery
02      Radiotherapy                                   Includes Teletherapy (external       beam
                                                       radiotherapy) and Brachytherapy.
03      Chemotherapy
04      Synchronous Chemoradiotherapy
05      Endobronchial                                  Includes Photodynamic therapy (PDT),
                                                       Electrocautery (Diathermy), Cryotherapy,
                                                       Laser Therapy, Bronchoscopic debulking,
                                                       Insertion of stents.
07      No active treatment (Supportive care)
08      Patient refused all therapies
09      Not recorded
11      Other therapy
12      No active treatment (Watchful waiting)

            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 60
13     Biological Therapy                             Includes Erlotinib, Gefitinib, Cetuximab,
                                                      Bevacizumab, Interferon, Interleukin 2,
                                                      BCG Vaccine etc.
14     Patient died before treatment

Related data item: Date of First Cancer Treatment

Notes by Users:




                                    Page revised 02/09/2010




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 61
Date of First Cancer Treatment
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This denotes the date the type of first cancer treatment was given to the patient.

Field Name: FIRSTTREATDATE
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
This field should be recorded for all patients including those with ‘no active
treatment’ (see below).
If type of first cancer treatment is ‘no active treatment’, the date recorded should be
the first date the decision was taken not to give the patient treatment as part of their
primary therapy. The aim of this date is to distinguish between patients who have
initially had no treatment but receive some therapy when symptoms develop.

The date recorded should be that of the first type of cancer treatment.

If the exact date is not documented, record as 09/09/0909.

If the patient died before treatment or the patient refused treatment, record as
10/10/1010.

Codes and values: N/A


Related data item: Type of First Cancer Treatment


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 62
Location Code {Cancer Surgery}
Common Name(s): Location, Location of Contact.

Main Source of Data Item Standard: Derived from SMR data standards.

Definition:
This is the reference number of any building or set of buildings where events
pertinent to NHS Scotland take place. Locations include hospitals, health centres,
GP surgeries, clinics, NHS board offices, nursing homes, schools and patient/client's
home.

Field Name: HOSPSURG
Field Type: Characters
Field Length: 5

Notes for Users:
Each location has a location code, which is maintained jointly by ISD and General
Register Office (Scotland).http://www.show.scot.nhs.uk/smrfiles/information.html –
datafiles

Location must be viewed as an address and not a code. If any new locations arise
where NHS healthcare is delivered/administered, please ensure that the Reference
Files Team at ISD is informed using form LOC-NEW (which can be downloaded from
the website below) so that a new code may be issued as appropriate.
http://www.show.scot.nhs.uk/smrfiles

Information about location should be electronically stored, managed and transferred
using the relevant location code. IT systems should allow the recording and display
of locations on the user interface as the relevant location name and associated
address, etc.

Examples of codes are given below.
  Code                             Institution
A111H     CROSSHOUSE HOSPITAL
C418H     ROYAL ALEXANDRA HOSPITAL
F704H     VICTORIA HOSPITAL, KIRKCALDY
G107H     GLASGOW ROYAL INFIRMARY
G405H     SOUTHERN GENERAL HOSPITAL, GLASGOW

If the location code is not documented, record as X9999.

If the patient has not had surgery record as X1010.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Related Data Items:

Notes by Users:


           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 63
Surgery Performed

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This records whether or not the patient had any surgery with the intention of
resecting the lung cancer.

Field Name: SURG
Field Type: Characters
Field Length: 2

Notes for Users:
In some cases the patient may not be fit for surgery or the extent of disease means
that surgery is not an option and therefore surgery is not mentioned in the case
notes. In these cases record as ‘no-reason documented’.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
  Code    Value
   01     Yes
   02     No - reason documented
   03     No - reason not documented
   95     Patient refused active treatment
   99     Not recorded




Related Data Items: Date of Surgery



Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 64
Date of Surgery

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date the main (definitive) surgery was performed.

Field Name: DSURG
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
This is the date of tumour resection and not the date of any diagnostic surgical
procedures.

If the exact date of surgery is not known, record as 09/09/0909.

If no surgery was performed, record as 10/10/1010 (inapplicable).

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.


Codes and Values: N/A

Related Data Items: Surgery Performed

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 65
Type of Surgery

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the main (definitive) operation performed on the patient for treatment of their
lung cancer.

Field Name: SURGTYPE
Field Type: Characters
Field Length: 2

Notes for Users:
A pneumonectomy is the surgical removal of an entire lung (either left or right). A
lobectomy is the removal of an entire lobe of a lung (there are three lobes in the right
lung and two in the left). Within lobes, the lungs are further divided into anatomical
segments (ten in the right lung and eight in the left). A segmental resection is the
removal of an anatomically defined segment of the lung and not the complete lobe.
A wedge resection is another surgical technique which involves the removal of a
piece of the lung.

Users should augment code ‘98 – Other (specify)’ with a free text field for recording
other values of this item.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
  Code    Value
   01     Pneumonectomy
   02     Lobectomy
   03     Wedge
   04     Segmental
   05     Pleurectomy
   06     Inoperable
   96     Not applicable
   98     Other, specify
   99     Not recorded


Related Data Items: Surgery Performed, Date of Surgery


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 66
Surgical Approach
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The type of surgical procedure(s) performed for investigation and/or treatment of
cancer

Field Name: APPROACH
Field Type: Characters
Field length: 2

Notes for Users:
All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
Code   Value                       Explanatory Notes

01     Open
02     Video assisted
96     Not applicable              e.g. Surgery not performed.
99     Not known


Related Data Items: Type of Surgery

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 67
Therapeutic Thoracoscopy (VATS)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
A record of whether thoracoscopy was performed for the purposes of treatment

Field Name: VATS
Field Type: Characters
Field Length: 2

Notes for Users:
Users may wish to augment code ‘98 – Other (specify)’ with a free text field for
recording other values of this item.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
  Code    Description
   00     None
   01     Surgical Pleurodesis
   95     Patient refused therapeutic thoracoscopy
   96     Not applicable
   98     Other, specify
   99     Not recorded


Related Data Items: Date of Therapeutic Thoracoscopy (VATS)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 68
Date of Therapeutic Thoracoscopy

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date the thoracoscopy was performed for the purposes of treatment.

Field Name: VATSDATE
Field Type: Date (DD/MM/CCYY).
Field Length: 10

Notes for Users:
If the exact date is not documented, record as 09/09/0909.

If therapeutic thoracoscopy was not performed, record as 10/10/1010 (inapplicable).

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.


Codes and Values: N/A

Related Data Items: Therapeutic Thoracoscopy (VATS)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 69
Date Discussed by Care Team (Post-Surgery)}
Common Name(s): Date discussed by multidisciplinary team {Cancer}.

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: This denotes the date the care team meeting was held to discuss the
management of the patient's care after surgery.

Field Name: MDTPOSTSURGDATE
Field Type: Date (DD/ MM /CCYY)
Field Length: 10

Notes for Users:
A cancer multidisciplinary care team may include surgeons, oncologists, radiologists,
pathologists, nurses, speech language therapists, physiotherapists and others
relevant to the treatment of a specific cancer. The team meets on a regular basis to
discuss optimal patient management. Documentation of the discussion should be
included in the case-note or other formal documentation.

The first MDT meeting date after surgery will be recorded.

If the exact date is not documented, record as 09/09/0909.

If the patient has not been discussed by the multidisciplinary team record as
10/10/1010.

Related Data Items:


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 70
Reason Not Discussed by Care Team (Post-Surgery)
Common Name(s): Reason not discussed by multidisciplinary team {Cancer}.

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The reason the proposed management and treatment of the patient/client was not
discussed by the care/multidisciplinary team.

Field Name: REASONNOMDTPOSTSURG
Field Type: Characters
Field Length: 2

Notes for Users:
Some issues will not need to be reviewed by an MDT, some will be reviewed once
only and others may require a weekly review on an ongoing basis.

Users may wish to augment code ‘98 – Other (specify)’ with a free text field for
recording other values of this item.

Codes and Values:
 Code           Value
 00             No reason given
 01             Not indicated
 02             Clinical decision
 03             Care team not available
 04             Patient declined
 05             Patient died
 98             Other, specify
 96             Not applicable
 99             Not known

Related Data Items: Date Discussed by Care Team (Post-surgery)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 71
Care Team Meeting Actions Recorded (Post-Surgery)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: A record of whether the care team meeting actions were recorded at the
MDT meeting.

Field Name: MDTACTPOSTSURG
Field Type: Characters
Field Length: 2

Notes for Users:
None.

Codes and Values:
Code    Description
00      No
01      Yes
96      Not applicable
99      Not known

Related Data Items: Date Discussed by Care Team

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 72
Histology (Post-Surgical)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This refers to the histology of the specimen obtained from the main (definitive)
surgical operation, as opposed to any specimens that may have been obtained pre-
surgically (bronchoscopies etc.).

Field Name: SURGHIST
Field Type: Characters
Field Length: 2

Notes for Users:
For post-surgical histology, the WHO classification should be applied in full detail.

Pathology taken after a patient had initially refused further investigation or
whose initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code    Value                                        Explanatory Notes
51      Squamous                                     includes all variants
52      Adenocarcinoma                               includes all variants and patterns
53      Large cell carcinoma                         excludes large         cell   neuroendocrine
                                                     carcinoma
61      Small cell carcinoma (SCLC)                  includes formerly used terms oat cell,
                                                     intermediate cell type and combined
                                                     SCLC/NSCLC cases
62      Large cell neuroendocrine
64      Typical Carcinoid

63      Atypical Carcinoid
85      Sarcomatoid Carcinomas                       includes all diagnoses of sarcomatoid,
                                                     pleomorphic or giant cell carcinomas
86      Salivary-type carcinomas                     includes   adenoid     cystic           and
                                                     mucoepidermoid tumours
71      Mixed non-small cell                         Includes adenosquamous and other
                                                     mixed NSCLC types
55      Unclassifiable/Undifferentiated non-
        small cell, not otherwise specified
        (NOS).
82      Non-epithelial malignancy
84      Others
91      Mesothelioma Unspecified
92      Epithelioid Mesothelioma
93      Sarcomatoid/Spindle Cell
        Mesothelioma
94      Biphasic Mesothelioma
            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 73
9      Not recorded
10     Inapplicable

Related Data Items: Surgery Performed, Date of Surgery

Notes by Users:




          National Data Definitions for National Minimum Core Data Set for Lung Cancers
                          Developed by ISD Scotland, 2010 Version 2.1


                                               Page 74
Residual Tumour
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: An indicator of whether the tumour was completely excised.

Field Name: RESIDUAL
Field Type: Characters
Field length: 2

Notes for Users:
Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
 Code Value
 00     No
 01     Yes
 96     Not applicable
 99     Not known


Related Data Items: Surgery Performed, Date of Surgery


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 75
TNM Tumour Classification (Pathological) (Lung Cancer)
Common name: Pathological TNM Tumour Classification (Lung Cancer)

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
A record of the size and extent of the tumour of the lung following resection of the
primary cancer.

Field Name: PTLUNG
Field Type: Characters
Field length: 3

Notes for Users:
In the case of multiple simultaneous tumours in one or two lungs, the tumour with the
highest T category should be used for classification.

Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code Value        Sub-             Sub-value         Explanatory Notes
                  code
00     TNM                                    No evidence of primary tumour
       Classification
       pT0
01     TNM                                    Carcinoma in situ (CIS)
       Classification
       pTis
02     TNM            Tumour up to ≤ 3cm, surrounded by lung or visceral pleura, without
       Classification bronchoscopic evidence of invasion more proximal than the lobar
       pT1            bronchus (i.e. not the main bronchus).
                        A          ≤ 2cm             The uncommon superficial spreading
                                                     tumour of any size with its invading
                                                     component limited to the bronchial wall,
                                                     which may extend proximal to the main
                                                     bronchus, is also classified as T1a.
                        B          > 2cm – 3cm

03     TNM            Tumour > 3cm to ≤ 7cm, Involves Main bronchus ≥ 2cm distal to
       Classification the carina, or invades visceral pleura, or associated with
       pT2            atelectasis or obstructive pneumonia that extends to the hilar region
                      but does not involve the entire lung.
                        A          > 3cm – 5cm T2 tumours with above features are
                                               classified as T2a if 5cm of less, or if size
                                               cannot be determined.
                        B          > 5cm – 7cm T2 tumours with above features are
                                               classified as T2b if greater than 5cm but not
                                               larger than 7cm.


            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 76
04     TNM            Tumour > 7cm; or Tumour of any size that directly invades any of
       Classification the following: chest wall (including superior sulcus tumours),
                      diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium;
                      or tumour in the main bronchus < 2cm distal to the carina but
                      without the involvement of the carina; or associated atelectasis or
                      obstructive pneumonitis of the entire lung or separate tumour
                      nodule(s) in the same lobe as the primary.

05     TNM            Tumour of any size that invades any of the following:
       Classification Mediastinum, heart, great vessels, trachea, recurrent laryngeal
       pT4            nerve, oesophagus, vertebral body; carina, separate tumour
                      nodule(s) in a different ipsilateral lobe to that of the primary.

06     TNM                                          Primary tumour cannot be assessed
       Classification
       pTX
96     Not
99     Not known

Related Data Items:
TNM Nodal Classification (Pathological) (Lung Cancer)
TNM Metastases Classification (Pathological) (Lung Cancer)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 77
TNM Nodal Classification (Pathological) (Lung Cancer)
Common name: Pathological TNM Nodal Classification (Lung Cancer).

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The extent of regional lymph node metastases as detected by microscopy.

Field Name: PNLUNG
Field Type: Characters
Field length: 2

Notes for Users:
Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code Value                          Explanatory Notes
00     TNM Classification           No regional lymph nodes metastasis.
       pN0
01     TNM Classification           Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph
       pN1                          nodes and intrapulmonary nodes, including involvement by direct
                                    extension.
02     TNM Classification           Metastasis in ipsilateral mediastinal and/or subcarinal lymph
       pN2                          node(s).
03     TNM Classification           Metastasis in contralateral mediastinal, contralateral hilar,
       pN3                          ipsilateral or contralateral scalene, or supraclavicular lymph
                                    node(s).
04     TNM Classification           Regional lymph nodes cannot be assessed (e.g. previously
       pNX                          removed).
96     Not applicable
99     Not known

Related Data Items:
TNM Tumour Classification (Pathological) (Lung Cancer)
TNM Metastases Classification (Pathological) (Lung Cancer)


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 78
TNM Metastases Classification (Pathological) (Lung Cancer)
Common name: Pathological TNM Metastases Classification (Lung Cancer).

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
The extent of metastatic spread of the tumour as detected by microscopy.

Field Name: PMLUNG
Field Type: Characters
Field length: 3

Notes for Users:
Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code Value                Sub- Sub-value                                  Explanatory Notes
                          code
00     TNM                                                                No distant metastasis (at autopsy only).
       Classification                                                     i.e. pM0 does not exist and is not valid
       pM0                                                                except at autopsy.
01     TNM                Distant Metastasis
       Classification
       pM1
                          A        Separate tumour nodule(s) in           Most pleural (pericardial) effusions with
                                   a contralateral lobe; tumour           lung cancer are due to tumour. In a few
                                   with pleural nodules or                patients, multiple microscopical
                                   malignant pleural or pericardial       examinations of pleural (pericardial) fluid
                                   effusion.                              are negative for tumour, and the fluid is
                                                                          non-bloody and is not an exudate. Where
                                                                          these elements and clinical judgement
                                                                          dictate that the effusion is not related to
                                                                          the tumour, the effusion should be
                                                                          excluded as a staging element and the
                                                                          patient should be classified as M0.

                          B        Distant metastasis
96     Not applicable
99     Not known                                                          e.g. M status not assessed.


Related Data Items:
TNM Nodal Classification (Pathological) (Lung Cancer)
TNM Tumour Classification (Pathological) (Lung Cancer)

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 79
TNM Tumour Classification (Pathological) (Pleural
Mesothelioma)
Common name: Pathological TNM Tumour stage (Pleural Mesothelioma)

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009).

Definition:
A record of the size and extent of the tumour following resection of the primary
cancer.

Field Name: PTMESO
Field Type: Characters
Field length: 3

Notes for Users:
There is no staging of peritoneal mesothelioma.

Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code Value                       Sub-        Sub-          Explanatory Notes
                                 code        value
00       TNM Classification No evidence of primary tumour
         pT0
01       TNM Classification Tumour involves ipsilateral parietal pleura, with or without focal
         pT1                involvement of visceral pleura.

                                 A           pT1a          Tumour involves ipsilateral parietal (mediastinal,
                                                           diaphragmatic) pleura. No involvement of visceral
                                                           pleura.
                                 B           pT1b          Tumour involves ipsilateral parietal (mediastinal,
                                                           diaphragmatic) pleura, with focal involvement of
                                                           the visceral pleura.
02       TNM Classification Tumour involves any ipsilateral pleural surfaces, with at least one of
         pT2                the following:
                            • Confluent visceral pleural tumour (including the fissure)
                            • Invasion of diaphragmatic muscle
                            • Invasion of lung parenchyma.
03       TNM Classification Tumour involves any ipsilateral pleural surfaces, with at least one of
         pT3*               the following:
                            • Invasion of endothoracic fascia
                            • Invasion into mediastinal fat
                            • Solitary focus of tumour invading soft tissues of the chest wall
                            • Non-transmural involvement of the pericardium.




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 80
04          TNM Classification Tumour involves any ipsilateral pleural surfaces, with at least one of
            pT4†               the following:
                               • Diffuse or multifocal invasion of the soft tissues of chest wall
                               • Any involvement of rib
                               • Invasion through diaphragm to peritoneum
                               • Invasion of any mediastinal organ(s)
                               • Direct extension to contralateral pleura
                               • Invasion into the spine
                               • Extension to internal surface of pericardium
                               • Pericardial effusion with positive cytology
                               • Invasion of myocardium
                               • Invasion of brachial plexus.
05          TNM Classification Primary tumour cannot be assessed
            pTX

96          Not applicable         Diagnosis is not mesothelioma
99          Not known

*
    T3 describes locally advanced but potentially resectable tumour.
†
    T4 describes locally advanced, technically unresectable tumour.

Related data items:
TNM Nodal Classification (Pathological) (Pleural Mesothelioma)
TNM Metastases Classification (Pathological) (Pleural Mesothelioma)

Notes by Users:




              National Data Definitions for National Minimum Core Data Set for Lung Cancers
                              Developed by ISD Scotland, 2010 Version 2.1


                                                   Page 81
TNM Nodal Classification (Pathological) (Pleural
Mesothelioma)
Common name: Pathological TNM Nodal stage (Pleural Mesothelioma)

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009)

Definition: A record of the extent of regional lymph node metastases.

Field Name: PNMESO
Field Type: Characters
Field length: 2

Notes for Users:
There is no staging of peritoneal mesothelioma.

Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and Values:
Code Value                           Explanatory Notes

00     TNM Classification pN0 No regional lymph nodes metastasis.

01     TNM Classification pN1 Metastasis in ipsilateral bronchopulmonary and/or hilar lymph node(s).

02     TNM Classification pN2 Metastasis in subcarinal lymph node(s) and/or ipsilateral internal
                              mammary or mediastinal lymph node(s).
03     TNM Classification pN3 Metastasis in contralateral mediastinal, internal mammary or hilar
                              node(s) and/or ipsilateral or contralateral supraclavicular or scalene
                              lymph node(s).
04     TNM Classification pNX Regional lymph nodes cannot be assessed (e.g. previously removed).

96     Not applicable                Diagnosis is not mesothelioma
99     Not known

Related Data items:
TNM Tumour Classification (Pathological) (Pleural Mesothelioma)
TNM Metastases Classification (Pathological) (Pleural Mesothelioma)


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 82
TNM Metastases Classification (Pathological) (Pleural
Mesothelioma)
Common name: Pathological TNM Metastases Classification (Pleural
Mesothelioma)

Main Source of Data Item Standard: TNM Classification (TNM Classification of
Malignant Tumours, Seventh Edition, UICC, 2009)

Definition: A record of the extent of metastatic spread of the tumour as detected by
microscopy.

Field Name: PMMESO
Field Type: Characters
Field length: 2

Notes for Users:
There is no staging of peritoneal mesothelioma.

Pathology taken after a patient had initially refused further investigation or whose
initial treatment is ‘Watch and Wait’ can also be recorded.

Codes and values:
Code Value                                   Explanatory Notes
00     TNM Classification pM0                No distant metastases.
01     TNM Classification pM1                Distant metastases present.
96     Not applicable                        e.g. Diagnosis is not mesothelioma

99     Not known                             M status is not assessed.


Related data items:
TNM Nodal Classification (Pathological) (Pleural Mesothelioma);
TNM Tumour Classification (Pathological) (Pleural Mesothelioma)


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 83
               Section 6: Radiotherapy




National Data Definitions for National Minimum Core Data Set for Lung Cancers
                Developed by ISD Scotland, 2010 Version 2.1


                                     Page 84
Radiotherapy

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
Radiotherapy is the treatment of the disease by radiation.

Field Name: RADIO
Field Type: Characters
Field Length: 2

Notes for Users:
Up to three separate courses of radiotherapy can be recorded and up to three
different sites of the body treated. The treatment to different sites may run
concurrently or consecutively.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
  Code    Value
   01     Yes
   02     No - reason documented
   03     No - reason not documented
   95     Patient refused active treatment
   99     Not recorded

Related Data Items:


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 85
Patient Eligible for Continuous Hyperfractionated Accelerated
Radiotherapy (CHART)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
An indication of whether or not the patient is eligible for CHART.

Field Name: CHART
Field Type: Characters
Field Length: 2

Notes for Users:
All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
  Code    Value
   00     No
   01     Yes
   95     Patient refused active treatment
   99     Not recorded

Related Data Items:


Notes by Users




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 86
Radiotherapy Course Type 1-3
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: The type of course of external beam radiotherapy administered for the
treatment of the cancer.

Field Name: RADIOTYPE 1-3
Field Type: Characters
Field length: 3

Notes for Users:
Combined treatments may be administered concurrently/synchronously e.g.
chemotherapy and radiotherapy, intra-operative radiotherapy.

For the purposes of national audit single or combined therapy does not apply to
Prophylactic radiotherapy.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
Code     Value                       Sub-         Sub-value                        Explanatory Notes
                                     code
00       None
01       Adjuvant                    A            Single Therapy                   It is given after potentially
                                     B            Combined                         curative      surgery     or
                                                  (synchronous) therapy            chemotherapy.
02       Radical                     A            Single Therapy                   It is primary treatment
                                     B            Combined                         and is given with curative
                                                  (synchronous) therapy            intent.
03       Palliative                  A            Single Therapy                   The aim is solely to
                                     B            Combined                         relieve symptoms.
                                                  (synchronous) therapy
04       Neo-adjuvant                A            Single Therapy                   It   is     given    before
                                     B            Combined                         potentially         curative
                                                  (synchronous) therapy            surgery.
05       Prophylactic                                                              The aim is to reduce the
                                                                                   risk of development of
                                                                                   disease e.g. prophylactic
                                                                                   cranial irradiation.
96       Not applicable                                                            e.g. no external beam
                                                                                   radiotherapy given.
99       Not known

Related Data Items:
Date Treatment Started (Radiotherapy) 1-3
Site of Radiotherapy (Courses 1-3)

Notes by Users:



           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 87
Site of Radiotherapy (Courses 1- 3)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the anatomical site(s) where the radiotherapy was given to the patient.

Field Name: RADIOSITE 1-3
Field Type: Characters
Field Length: 2

Notes for Users:
Up to three separate courses of radiotherapy can be recorded and up to three
different sites of the body treated. Radiotherapy recorded is only that which was
given at the time of the initial treatment episode; the treatment to different sites may
run concurrently or consecutively.

Users may wish to augment code ‘98 – Other (specify)’ with a free text field for
recording other values of this item.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
 Code       Value                  Explanatory notes
  01        Chest
  02        Brain                If Prophylactic Cranial Irradiation (PCI)
                                 radiotherapy is given then record site as
                                 brain.
   03      Bone
   96      Inapplicable
   98      Other, specify        Includes pleural drain
   99      Not recorded


Related Data Items: Radiotherapy Course Type 1-3


Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 88
Date Treatment Started {Cancer} (Radiotherapy) 1-3

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services

Definition:
The date cancer treatment course commenced.

Field Name: RSRTDATE 1-3
Field Type: Date (DD/MM/CCYY)
Field length: 10

Notes for Users:
This is the first fraction of a course of external beam radiotherapy, or brachytherapy.

Up to three courses may be recorded

If the date treatment started is unknown, record as 09/09/0909.
If treatment has not been given, record as inapplicable, 10/10/1010.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and values: N/A

Related Data Items: Date Treatment Completed {Cancer} (Radiotherapy) 1-3




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                 Page 89
Date Treatment Completed {Cancer} (Radiotherapy) 1-3

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services

Definition:
The date cancer treatment course ended.

Field Name: RCOMPDATE 1-3
Field Type: Date (DD/MM/CCYY)
Field Length: 10


Notes for Users:
This is the last fraction of a course of external beam radiotherapy, or brachytherapy.

It should be noted this can be the same day as the day the therapy started.

Up to three courses may be recorded

If the date treatment completed is unknown, record as 09/09/0909.
If treatment has not been given, record as inapplicable, 10/10/1010.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.


Codes and values: N/A

Related Data Items: Date Treatment Started {Cancer} 1-3

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 90
Radiotherapy Dose: Total Administered {Cancer} 1-3
Common name: Total External Beam Radiotherapy Dose Administered {Cancer}

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services

Definition: The Tumour Applied Dose (TAD) actually given (recorded in Gy)
between the start and completion dates recorded for the course.

Field Name: TOTDOSE 1-3
Field Type: Float nn.nn
Field length: 5

Notes for Users:
IT systems should ensure that the unit of measurement for values is always clear to
users, in whatever medium values are recorded.

Up to three courses may be recorded

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values: N/A

Sub Data item: Status
Code         Value                      Explanatory Notes
96           Not applicable             If External Beam Radiotherapy was not given,
                                        code as Not applicable
99            Not known                 Includes Not recorded

Related Data Items:


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 91
Radiotherapy Fractions: Total Administered {Cancer} 1-3
Common name:            Total External Beam Radiotherapy Fractions Administered
{Cancer}

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: The number of radiation treatments actually given for any individual
course of therapy (described by the start and completion dates of External Beam
Radiotherapy).

Field Name: FRACTIONS 1-3
Field Type: Integer
Field length: 2

Notes for Users:
Up to three courses may be recorded

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.


Codes and Values: N/A

Sub Data item: Status
Code Value                                     Explanatory Notes
96     Not applicable                          If no External Beam Radiotherapy was given record
99     Not known                               Includes Not recorded.

Related data items:

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 92
Type of Radiotherapy Fractionation Schedule 1-3

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The type of fractionation schedule detailed in the external beam radiotherapy
prescription.

Field Name: FRACSCHED 1-3
Field Type: Characters
Field length: 2

Notes for Users:
Users may wish to augment code ‘98 – Other (specify)’ with a free text field for
recording other values of this item.

Up to three courses may be recorded.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
Code    Value                           Explanatory Notes
00        None
01        Single fraction
02        Continuous                    Includes CHART.
03        Scheduled gap                 Phased regimen e.g. 2 weeks continuous therapy then 2
                                        week gap then further 2 week continuous therapy.
98        Other (specify)

Related data items:
Radiotherapy Dose: Total Administered {Cancer} 1-3
Date Treatment Started {Cancer} (Radiotherapy) 1-3
Date Treatment Completed {Cancer} (Radiotherapy) 1-3


Notes by Users:




                                   Page revised 02/09/2010




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 93
           Section 7: Systemic Therapy




National Data Definitions for National Minimum Core Data Set for Lung Cancers
                Developed by ISD Scotland, 2010 Version 2.1


                                     Page 94
Treatment Status {Cancer} (Systemic Therapy)

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
A record of whether or not the patient had systemic therapy delivered for the
management of their cancer.

Field Name: CHEM
Field Type: Characters
Field Length: 2

Notes for Users:
All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
  Code    Value
   01     Yes
   02     No - reason documented
   03     No - reason not documented
   95     Patient refused active treatment
   99     Not recorded

Related Data Items:


Notes by Users:




                                   Page revised 02/09/2010




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 95
Systemic Therapy Type {Cancer} 1-3
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The type of course of cytotoxic or biological drugs administered for the treatment of
the cancer.

Field Name: CHEMTYPE 1-3
Field Type: Characters
Field Length: 2

Notes for Users:
Patients may have chemotherapy both before and after surgery.

Up to three courses may be recorded.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and values:
Code     Value                       Explanatory Notes
01       Neoadjuvant              Therapy given prior to definitive surgery to reduce tumour size
02       Adjuvant                 Therapy given after surgery where there is no overt evidence
                                  of remaining disease
03         Primary                Chemotherapy given as first line therapy with curative intent
                                  where there is no intention of surgical intervention.
04         Palliative             Chemotherapy given for symptom control without curative
                                  intent
96         Not applicable
99         Not known

Related Data Items: Date Treatment Started {Cancer} (Systemic Therapy)

Notes by Users:



                                   Page revised 02/09/2010




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 96
Systemic Therapy Agent (Lung Cancer) 1-3
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The type of chemotherapy or biological therapy used either alone or in combination
to treat lung cancer.

Field Name: CHEMAGENT 1-3
Field Type: Characters
Field length: 2

Notes for Users:
Chemotherapy drugs can be given in or outwith the context of a clinical trial.

Users may wish to augment code ‘98 – Other (specify)’ with a free text field for
recording other values of this item.

Up to three courses may be recorded.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values:
Code Value                                                   Explanatory notes
01     Cisplatin/Vinorelbine palliative and                  Non-small Cell
       neoadjuvant
02     Carboplatin/Vinorelbine                               Non-small Cell
03     Carboplatin/Gemcitabine                               Non-small Cell
04     Gemcitabine single agent                              Non-small Cell
05     Cisplatin/Etoposide                                   Non-small Cell & Small Cell
06     Cisplatin/Docetaxel                                   Non-small Cell
07     Cisplatin/Gemcitabine                                 Non-small Cell
08     Vinorelbine single agent                              Non-small Cell
09     Docetaxel single agent                                Non-small Cell
10     Cisplatin/Etoposide                                   Small Cell
11     Carboplatin/Etoposide                                 Small Cell
12     Carboplatin single agent                              Small Cell
13     Cyclophosphamide, Doxorubicin and                     Small Cell
       Vincristine (CAV)
14     Topotecan                                             Small Cell
15                                                           Mesothelioma & Non-small Cell
       Cisplatin/Pemetrexed

16     Erlotinib
17     Carboplatin/Pemetrexed                                Non-small Cell
96     Not applicable
98     Other (specify)
99     Not known

                                    Page revised 02/09/2010

           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 97
Chemotherapy Total Number of Cycles Administered
{Cancer} 1-3
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
The total number of chemotherapy cycles actually delivered to the patient.

Field Name: CYCLES 1-3
Field Type: Integer
Field Length: 3

Notes for Users:
A pulse is the basic unit of chemotherapy and will normally equate to a single
contact with a chemotherapy nurse specialist. Several drugs may be delivered in
one pulse. A cycle denotes the repeating pattern within many chemotherapy
programmes/agents. A new cycle commences when the original pattern starts
again.
A cycle can be given on one or more days of a two to four week interval.

Up to three courses may be recorded.

If the number of cycles is not documented, record as X99.
If treatment has not been given, record as inapplicable, X96.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and Values: N/A

Related Data Items:
Date Treatment Started {Cancer} (Systemic Therapy)
Date Treatment Completed {Cancer} (Systemic Therapy)

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 98
Date Treatment Started {Cancer} (Systemic Therapy) 1-3
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: The date cancer treatment course commenced.

Field Name: CHEMDATE 1-3
Field Type: Date (DD/MM/CCYY)
Field length: 10

Notes for Users:
This is the first dose of the first cycle of a course of chemotherapy or biological
therapy.

Up to three courses may be recorded.

If the date treatment started is unknown, record as 09/09/0909.
If treatment has not been given, record as inapplicable, 10/10/1010.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and values: N/A

Related data items:
Treatment Status {Cancer} (Systemic Therapy)
Date Treatment Completed {Cancer} (Systemic Therapy)


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                                Page 99
Date Treatment Completed {Cancer} (Systemic Therapy) 1-3
Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: The date cancer treatment course ended.

Field Name: CHEMENDATE 1-3
Field Type: Date (DD/MM/CCYY)
Field length: 10

Notes for Users:
This is the last dose of the last cycle of a course of chemotherapy, or biological
therapy.

It should be noted this can be the same day as the day the therapy started.

Up to three courses may be recorded.

If the date treatment started is unknown, record as 09/09/0909.
If treatment has not been given, record as inapplicable, 10/10/1010.

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.

Codes and values: N/A

Related data items: Date Treatment Started {Cancer}

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                               Page 100
              Section 8: Other Therapy




National Data Definitions for National Minimum Core Data Set for Lung Cancers
                Developed by ISD Scotland, 2010 Version 2.1


                                    Page 101
Date of Endobronchial Treatment

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the date the endobronchial treatment, not described elsewhere, and was
performed for the purposes of treatment.

Field Name: ENDODATE
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
If the exact date is not documented, record as 09/09/0909.

If no other therapy was performed, record as 10/10/1010 (inapplicable).

All treatments given as part of the initial treatment plan plus second-line
treatment received within six months of diagnosis should be recorded.


Codes and Values: N/A

Related Data Items: N/A


Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                               Page 102
               Section 9: Clinical Trials




National Data Definitions for National Minimum Core Data Set for Lung Cancers
                Developed by ISD Scotland, 2010 Version 2.1


                                    Page 103
Participant in Clinical Trial

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition: A record of whether or not the patient received treatment within the
context of a clinical trial.

Field Name: TENTRY
Field Type: Characters
Field length: 2

Notes for Users:
Clinical trials are ‘a research activity that involves the administration of a test
regimen to humans to evaluate its efficacy and safety.’
(Source: Last JM. A Dictionary of Epidemiology, 2nd edition.)

This relates only to participation in clinical trials which may be local, national or
international. Trials can be drug company sponsored and monitored.

Codes and Values:
Code    Value
00      No
01      Yes
96      Not applicable
99      Not known

Related Data Items: N/A

Notes by Users:




           National Data Definitions for National Minimum Core Data Set for Lung Cancers
                           Developed by ISD Scotland, 2010 Version 2.1


                                               Page 104
      Section 10: Follow-Up and Death




National Data Definitions for National Minimum Core Data Set for Lung Cancers
                Developed by ISD Scotland, 2010 Version 2.1


                                    Page 105
Date of Death

Main Source of Data Item Standard: The National Cancer Audit Datasets
developed by the regional Cancer Networks supported by Information Services.

Definition:
This is the certified date of death as recorded by the General Register Office
(Scotland) (GRO(S)).

Field Name: DOD
Field Type: Date (DD/MM/CCYY)
Field Length: 10

Notes for Users:
If the exact date is not documented, record as 09/09/0909.

If the patient is still alive, record as 10/10/1010 (inapplicable)

Codes and Values:

Related Data Items:

Notes by Users:




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                Page 106
Underlying Cause of Death
Common name: Cause of Death

Main Source of Data Item Standard: GRO(S)

Definition:
The underlying cause of death as recorded by GRO(S) in Part I of the death
certificate.

Field Name: COD
Field Type: Characters ICD10 code, ann.n or ann.a e.g. C34.9
Field length: 4

Notes for Users:
This refers only to the underlying cause of death, which is the condition recorded in
the lowest completed line of Part I of the death certificate.

In cases where a post mortem examination has been performed, the underlying
cause of death recorded by the pathologist should replace any preceding entry. In
cases where the Procurator Fiscal has been involved, the final underlying cause of
death recorded by them should supersede any previous entry.

The mode of dying, such as cardiac arrest or asphyxia, should not be recorded here.
Other significant conditions contributing to the death but not related to the disease or
condition causing it, as recorded in Part II of the death certificate, should not be
recorded here.

If the cause of death is unknown record as 99.
If the patient is still alive, record as not applicable 96.

Codes and values: N/A

Related Data Items: Date of Death

Notes by Users:




                                       Page revised 02/09/2010




            National Data Definitions for National Minimum Core Data Set for Lung Cancers
                            Developed by ISD Scotland, 2010 Version 2.1


                                                Page 107
                                                                                    APPENDIX 1
          DOWNLOAD FORMAT
          To assist with downloading data to ISD for the National Quality Assurance Programme and other agreed activities, all sites should be able export data
          according to the following specification.

          DATABASE SPECIFICATION AND VALIDATIONS

Data item                         Field name          Field type    Size       Validations                                                                                          Page
Section 1: Patient identifiers                                                                                                                                                         1
Person Family Name (at            PATSNAME            Character         35     1. None                                                                                                 2
Diagnosis)
Person Given Name                 PATFNAME            Character         35     1. None                                                                                                 3
Patient Postcode at Diagnosis     PATPCODE            Character            8   1. Must be a valid code as listed in national postcode reference files                                  4
{Cancer}
Date of Birth                     DOB                 Date              10     1. Format DD/MM/CCYY                                                                                    5
                                                                               2. Must be a valid date before today’s date and all other dates
Person Sex at Birth               SEX                 Integer              1   1. Must be a valid code as detailed in the national data definitions                                    6
Location of Diagnosis (Cancer)    HOSP                Character            5    1. Format alpha numeric ‘ANNNA’ or ‘ANNNN (see 3 and 4 below)                                          7
                                                                                2. Must be a valid code as listed in national reference file http://www.natref.scot.nhs.uk/
                                                                                3. Cannot be X1010 (Not applicable)
                                                                                4. Can be X9999 (Not known)
Health Record Identifier          UNITNUM             Character         14     1. Can be Null                                                                                          8
CHI Number                        CHINUM              Character         10     1.   10 digit integer which could contain a leading ‘Zero’                                              9
                                                                               2.   First 6 digits must cross check with Date of Birth (DD/MM/YY))
                                                                               3.   Must be a valid CHI number and meet check digit checks
                                                                               4.   If the 9th digit of the CHI number is odd SEX should be male (code 1), and if even (including
                                                                                    0) then SEX should be female (code 2)
                                                                               5.   Valid CHI numbers that are submitted without a leading zero must be stored with the
                                                                                    leading zero back in.
                                                                               6.   Can be null
Section 2: Referral Details and Hospital Clinicians                                                                                                                                   10
Cancer Registration Incidence     INCDATE             Date              10     1. Format DD/MM/CCYY                                                                                   11
Date                                                                           2. Must be a valid date on or before today’s date

                                                      National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                      Developed by ISD Scotland, 2010 Version 2.1


                                                                                           Page 1
Date of Cancer Referral            REFDATE      Date              10    1. Format DD/MM/CCYY                                                             12
                                                                        2. Must be a valid date on or before today’s date
                                                                        3. Must not be 10/10/1010 (Not applicable)
                                                                        4. Can be 09/09/0909 (Not known)
Date Referral Received             REFRECDATE   Date              10    1. Format DD/MM/CCYY                                                             13
                                                                        2. Must be a valid date on or before today’s date
                                                                        3. Must not be 10/10/1010 (Not applicable)
                                                                        4. Can be 09/09/0909 (Not known)
Source of Cancer Referral          MREFER       Character           2   1. Must be a valid code as detailed in the national data definitions             14
                                                                        2. Cannot be 10 (Inapplicable)
Urgency of Cancer Referral         URGENCYREF   Character           2   1. Must be a valid code as detailed in the national data definitions             15
                                                                        2. Can be 09 (Not recorded)
                                                                        3. Can be 10 (Inapplicable)
Clinician 1                        CLINAM1      Character         20    1. Must be a valid GMC number as listed in the national reference files          16
                                                                        2. Must not be 1010 (Not applicable)
                                                                        3. Can be 9999 (Not known)
                                                                        4. Can be LOCUM
Specialty of Clinician 1           CLINSPEC1    Character           3   1. Must be a valid code as listed in the national data definitions               17
                                                                        2. Must not be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
Date of Seeing First Clinician 1   FCLINDATE1   Date              10    1. Format DD/MM/CCYY                                                             19
                                                                        2. Must be a valid date on or before today’s date
                                                                        3. Must not be 10/10/1010 (Not applicable)
                                                                        4 Can be 09/09/0909 (Not known)
Clinician 2                        CLINAM2      Character         20    1. Must be a valid GMC number as listed in the national reference files          16
                                                                        2. Can be 1010 (Not applicable)
                                                                        3. Can be 9999 (Not known)
                                                                        4. Can be LOCUM
Specialty of Clinician 2           CLINSPEC2    Character           3   1. Must be a valid code as listed in the national data definitions               17
                                                                        2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
Date of Seeing First Clinician 2   FCLINDATE2   Date              10    1.   Format DD/MM/CCYY                                                           19
                                                                        2.   Must be a valid date on or before today’s date and on or after FCLINDATE1
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)



                                                National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                Developed by ISD Scotland, 2010 Version 2.1


                                                                                     Page 2
Clinician 3                        CLINAM3      Character         20    1. Must be a valid GMC number as listed in the national reference files        16
                                                                        2. Can be 1010 (Not applicable)
                                                                        3. Must be 1010 (Not applicable) when CLINAM2 = 1010 (Not applicable)
                                                                        4. Can be 9999 (Not known)
                                                                        5. Can be LOCUM
Specialty of Clinician 3           CLINSPEC3    Character           3   1. Must be a valid code as listed in the national data definitions             17
                                                                        2. Can be 96 (Not applicable)
                                                                        3. Must be 96 (Not applicable) when CLINAM3 = 1010 (Not applicable)
                                                                        4. Can be 99 (Not known)
Date of Seeing First Clinician 3   FCLINDATE3   Date              10    1. Format DD/MM/CCYY                                                           19
                                                                        2. Must be a valid date on or before today’s date and on or after FCLINDATE2
                                                                        3. Can be 10/10/1010 (Not applicable)
                                                                        4. Must be 10/10/1010 (Not applicable) when CLINAM3 = 1010 (Not applicable)
                                                                        5. Can be 09/09/0909 (Not known)
Clinician 4                        CLINAM4      Character         20    1. Must be a valid GMC number as listed in the national reference files        16
                                                                        2. Can be 1010 (Not applicable)
                                                                        3. Must be 1010 (Not applicable) when CLINAM3 = 1010 (Not applicable)
                                                                        4. Can be 9999 (Not known)
                                                                        5. Can be LOCUM
Specialty of Clinician 4           CLINSPEC4    Character           3   1. Must be a valid code as listed in the national data definitions             17
                                                                        2. Can be 96 (Not applicable)
                                                                        3. Must be 96 (Not applicable) when CLINAM4 = 1010 (Not applicable)
                                                                        4. Can be 99 (Not known)
Date of Seeing First Clinician 4   FCLINDATE4   Date              10    1. Format DD/MM/CCYY                                                           19
                                                                        2. Must be a valid date ON OR before today’s date and on or after FCLINDATE3
                                                                        3. Can be 10/10/1010 (Not applicable)
                                                                        4. Must be 1010 (Not applicable) when CLINAM4 = 1010 (Not applicable)
                                                                        5 Can be 09/09/0909 (Not known)
Date Discussed by Care Team        MDTDATE      Date              10    1. Format DD/MM/CCYY                                                           20
(Pre-treatment)                                                         2. Must be a valid date before today’s date
                                                                        3. Can be 10/10/1010 (Not applicable)
                                                                        4. Can be 09/09/0909 (Not known)
                                                                        5. Must be on or before FIRSTTREATDATE
Care Team Meeting Actions          MDTACTION    Character           2   1. Must be a valid code as listed in the national data definitions             21
Recorded                                                                2. Must be on or before FIRSTTREATDATE
                                                                        3. Can be 96 (Not applicable)
                                                                        4. Must be 96 (Not applicable) when MDTDATE = 10/10/1010 (Not applicable)
                                                                        5. Can be 99 (Not known)

                                                National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                Developed by ISD Scotland, 2010 Version 2.1


                                                                                     Page 3
Reason not Discussed by Care     REASONNOMDT    Character           2   1.   Must be a valid code as listed in the national data definitions   22
Team (Pre-treatment)                                                    2.   Can be 99 (Not known)
                                                                        3.   Cannot be 96 (Not applicable) when MDTACTION = 01 (Yes)
                                                                        4.   Can be 96 (Not applicable)
Reason not Discussed by Care    REASONNOMDT98 Character          150    1. Can be Null
Team - Other, specify                                                   2. Cannot be null if REASONNOMDT = 98 (Other, specify)
Section 3: Diagnostic Procedures, Staging and Assessment                                                                                       23
Date of Chest X-ray             XDATE               Date          10    1.   Format DD/MM/CCYY                                                 24
                                                                        2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Date of CT/MRI Thorax            CTTHORAXDATE   Date              10    1.   Format DD/MM/CCYY                                                 25
                                                                        2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Date of Integrated FDG-PET/CT    PETDATE        Date              10    1.   Format DD/MM/CCYY                                                 26
(PET/CT) Scan                                                           2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Date of CT/MRI Brain             CTBRAINDATE    Date              10    1.   Format DD/MM/CCYY                                                 27
                                                                        2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Date of Bronchoscopy {Lung       BDATE          Date              10    1.   Format DD/MM/CCYY                                                 28
Cancer}                                                                 2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Date of Endobronchial            EBUSDATE       Date              10    1.   Format DD/MM/CCYY                                                 29
Ultrasound (EBUS)                                                       2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Date of Image Guided Biopsy or   IMGUIDDATE     Date              10    1.   Format DD/MM/CCYY                                                 30
FNA of Lung                                                             2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Other Tissue Diagnosis           OTHSPECSITE    Character           3   1.   Must be a valid code as listed in the national data definitions   31
Specimen Site                                                           2.   Can be 96 (Not applicable)
                                                                        3.   Can be 99 (Not known)
                                                National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                Developed by ISD Scotland, 2010 Version 2.1


                                                                                      Page 4
Other Tissue Diagnosis            OTHSPECSITE98   Character        150    1.   Can be Null
Specimen Site - Other, specify                                            2.   Cannot be Null if OTHSPECSITE = 98 (Other, specify)
Date of Other Tissue Diagnosis    OTHDATE         Date              10    1.   Format DD/MM/CCYY                                                                            32
                                                                          2.   Must be a valid date before today’s date
                                                                          3.   Can be 10/10/1010 (Not applicable)
                                                                          4.   Must be 10/10/1010 (Not applicable) when OTHSPECSITE = 96 (Not applicable)
                                                                          5.   Can be 09/09/0909 (Not known)
Laterality {Cancer}               SIDE            Character           2   1.   Must be a valid code as listed in the national data definitions                              33
                                                                          2.   Cannot be 96 (Not applicable)
                                                                          3.   Can be 99 (Not known)
Origin of Tumour                  ORIGIN          Numeric             2   1. Must be a valid code as listed in the national data definitions                                34
Site of Tumour                    SITE            Character           5   1. Format ANN.N or NN (See 3 & 4 below)                                                           35
                                                                          2. Must be a valid code as listed in the national data definitions
                                                                          3. Can be 96 (Not applicable)
                                                                          4. Can be 99 (Not known)
Site of Tumour - Other, specify   SITE98          Character        150    1. Can be Null
                                                                          2. Cannot be Null if SITE = 98 (Other, specify)
Date of Diagnosis {Cancer}        DIAGDATE        Date              10    1. Format DD/MM/CCYY                                                                              36
                                                                          2. Must be a valid date on or before today's date
                                                                          3. When submitting data to ISD for national exercised, data must be within header row reference
                                                                             date parameters eg HEADER, CRLUNG, DUMMY, Reference Date XXXX,21, If the header
                                                                             reference date “XXXX” is 2010 then DIAGDATE must be ≥ 01 January 2010 and ≤ 31
                                                                             December 2010.
                                                                          4. Cannot be 10/10/1010 (Not applicable)
                                                                          5. Can be 09/09/0909 (Not known)
                                                                          6. Must be on or before Date of Death
Most Valid Basis of Diagnosis     VALID           Character           2   1.   Must be a valid code as listed in the national data definitions                              37
{Cancer}                                                                  2.   Cannot be code 10 for audit (DCO).
                                                                          3.   Cannot be Code 04 (Tumour markers) for lung.
                                                                          4.   Can be 9999 (Not recorded)
Date of Mediastinoscopy           MEDIASTDATE     Date              10    1.   Format DD/MM/CCYY                                                                            39
                                                                          2.   Must be a valid date on or before today’s date
                                                                          3.   Can be 10/10/1010 (Not applicable)
                                                                          4.   Can be 09/09/0909 (Not known)



                                                  National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                  Developed by ISD Scotland, 2010 Version 2.1


                                                                                        Page 5
Date of                             THORADATE   Date              10    1. Format DD/MM/CCYY                                                                            40
Thoracotomy/Thoracoscopy                                                2. Must be a valid date on or before today’s date
(VATS) (Pre-treatment)                                                  3. Must be before FIRSTTREATDATE
                                                                        4. Can be 10/10/1010 (Not applicable)
                                                                        5. Can be 09/09/0909 (Not known)
TNM Tumour Classification           TLUNG       Character           3   1. Must be a valid code as listed in the national data definitions                              41
(Clinical) (Lung Cancer)                                                2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
TNM Nodal Classification            NLUNG       Character           2   1. Must be a valid code as listed in the national data definitions                              43
(Clinical) (Lung Cancer)                                                2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
TNM Metastases Classification       MLUNG       Character           3   1. Must be a valid code as listed in the national data definitions                              44
(Clinical) (Lung Cancer)                                                2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
Synchronous Primary Tumours         MULTIPLE    Character           3   1. Must be a valid code as listed in the national data definitions                              45
                                                                        2. Can be 99 (Not known)
TNM Tumour Classification           TMESO       Character           3   1. Must be a valid code as listed in the national data definitions                              46
(Clinical) (Pleural Mesothelioma)                                       2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
TNM Nodal Classification            NMESO       Character           2   1. Must be a valid code as listed in the national data definitions                              48
(Clinical) (Pleural Mesothelioma)                                       2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
TNM Metastases Classification       MMESO       Character           2   1. Must be a valid code as listed in the national data definitions                              49
(Clinical) (Pleural Mesothelioma)                                       2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
WHO/ECOG Performance Status         PSTATUS     Character           1   1. Must be a valid code as listed in the national data definitions                              50
                                                                        2. Can be 9 (Not known)

Seen by Clinical Nurse Specialist CNS           Character           2   1. Must be a valid code as listed in the national data definitions                              51
(Lung Cancer / Mesothelioma)                                            2. Can be 99 (Not known)
Section 4: Pathology (Diagnostic)                                                                                                                                       52
Location Code {Cancer             PATHLAB       Character           5   1.   Format alpha numeric ‘ANNNA’ or ‘ANNNN (see 3 and 4 below)                                 53
Pathology}                                                              2.   Must be a valid code as listed in national reference file http://www.natref.scot.nhs.uk/
                                                                        3.   Can be X1010 (Not applicable)
                                                                        4.   Can be X9999 (Not known)
                                                National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                Developed by ISD Scotland, 2010 Version 2.1


                                                                                      Page 6
Date Histo/Cytopathological      PATHDATE         Date              10    1.   Format DD/MM/CCYY                                                                      55
Specimen Taken                                                            2.   Must be a valid date on or before today’s date
                                                                          3.   Can be 10/10/1010 (Not applicable)
                                                                          4.   Must be 10/10/1010 (Not applicable) if PATHLAB = X1010 (Not applicable)
                                                                          5.   Can be 09/09/0909 (Not known)
Histology/Cytology               HIST             Character           2   1.   Must be a valid code as listed in the national data definitions                        56
(Diagnostic/Pre-Surgery)                                                  2.   Can be 9 (Not recorded)
                                                                          3.   Can be 10 (Not applicable – Reason documented)
                                                                          4.   Can be 20 (Not applicable – Reason not documented)
                                                                          5.   Must be 10 or 20 if PATHDATE = 10/10/1010 (Not applicable)
Reason Histology/Cytology not    REASONNOHIST     Character           2   1.   Must be a valid code as listed in the national data definitions                        58
Performed                                                                 2.   Can be 96 (Not applicable)
                                                                          3.   Cannot be 96 (Not applicable) if PATHDATE = 10/10/1010 (Not applicable)
                                                                          4.   Must be 96 (Not applicable) if PATHDATE not equal to 10/10/1010 (Not applicable)
                                                                          5.   Can be 99 (Not known)
Section 5: Surgery and Post-Resection Pathology                                                                                                                       59
Type of First Cancer Treatment MODE1              Character           2   1. Must be a valid code as listed in the national data definitions                          60
Date of First Cancer Treatment   FIRSTTREATDATE   Date              10    1. Format DD/MM/CCYY                                                                        62
                                                                          2. Must be a valid date on or before today’s date
                                                                          3. Can only be 10/10/1010 (Not applicable) if MODE1 = 08 (Patient refused) or MODE1 = 14
                                                                             (Patient died before treatment)
                                                                          4. Can be 09/09/0909 (Not known)
                                                                          5. Must be on or before date of death
Location Code {Cancer Surgery}   HOSPSURG         Character           5   1. Format alphanumeric ‘ANNNA’ or ‘ANNNN’                                                   63
                                                                          2. Must be a valid code as listed in national reference file http:/www.natref.scot.nhs.uk
                                                                          3. Can be X1010 (Inapplicable)
                                                                          4. Can be X9999 (Not recorded)

Surgery Performed                SURG             Character           2   1. Must be a valid code as listed in the national data definitions                          64
                                                                          2. If SURG is recorded as 2 (No - Reason documented) or 3 (No - Reason not documented) or
                                                                             95 (Patient refused), then MULTIPLE must be 00 (No) and DSURG, SURGTYPE,
                                                                             SURGHIST, PTLUNG, PNLUNG and PMLUNG or PTMESO, PNMESO, PMMESO should be
                                                                             coded as inapplicable




                                                  National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                  Developed by ISD Scotland, 2010 Version 2.1


                                                                                       Page 7
Date of Surgery                    DSURG          Date              10    1.   Format DD/MM/CCYY                                                                    65
                                                                          2.   Must be a valid date on or before today’s date
                                                                          3.   Can be 10/10/1010 (Not applicable)
                                                                          4.   If DSURG is recorded 10/10/1010 (Not applicable), then SURG must be 2 (No - Reason
                                                                               documented) or 3 (No - Reason not documented) or 95 (Patient refused).
                                                                          5.   Can be 09/09/0909 (Not known)
                                                                          6.   Must be on or before date of death
Type of Surgery                    SURGTYPE       Character           2   1.   Must be a valid code as listed in the national data definitions                      66
                                                                          2.   Can be 96 (Not applicable)
                                                                          3.   If SURGTYPE is recorded 96 (Inapplicable) then SURG must be 2 (No - Reason
                                                                               documented) or 3 (No - Reason not documented) or 95 (Patient refused)

Type of Surgery - Other, specify   SURGTYPE98     Character        150    1. Can be Null
                                                                          2. Cannot be Null if SURGTYPE = 98 (Other, specify)
Surgical Approach                  APPROACH       Character           2   1. Must be a valid code as listed in the national data definitions                        67
                                                                          2. Can be 96 (Not applicable)
                                                                          3. Cannot be 01 (Open), 02 (Video assisted) or 99 (Not known) when SURGTYPE = 06
                                                                             (Inoperable) or 96 (Not applicable)
                                                                          3. Can be 99 (Not known)
Therapeutic Thoracoscopy           VATS           Character           2   1. Must be a valid code as listed in the national data definitions                        68
(VATS)                                                                    2. Can be 96 (Not applicable)
                                                                          3. Can be 99 (Not known)
Therapeutic Thoracoscopy           VATS98         Character        150    1.   Can be Null
(VATS) - Other, specify                                                   2.   Cannot be Null if VATS = 98 (Other, specify)
Date of Therapeutic                VATSDATE       Date              10    1.   Format DD/MM/CCYY                                                                    69
Thoracoscopy (VATS)                                                       2.   Must be a valid date on or before today’s date
                                                                          3.   Can be 10/10/1010 (Not applicable)
                                                                          4.   If VATS = 96 (Not applicable) then VATSDATE must be 10/10/1010 (Not applicable)
                                                                          5.    Can be 09/09/0909 (Not known)
                                                                          6.    Must be on or before date of death
Date Discussed by Care Team        MDTPOSTSURGD   Date              10    1.   Format DD/MM/CCYY                                                                    70
(Post-Surgery)                     ATE                                    2.   Must be a valid date on or before today’s date
                                                                          3.   Can be 10/10/1010 (Not applicable)
                                                                          4.   Can be 09/09/0909(Not known)
                                                                          5.   Must be on or after DSURG



                                                  National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                  Developed by ISD Scotland, 2010 Version 2.1


                                                                                       Page 8
Reason not Discussed by Care    REASONNOMDTP    Character           2   1. Must be a valid code as listed in the national data definitions                           71
Team (Post-Surgery)             OSTSURG                                 2. Must be 96 (Not applicable) if MDTPOSTSURGDATE = 10/10/1010 (Not applicable)
                                                                        4. Can be 99 (Not known)

Reason not Discussed by Care    REASONNOMDTP    Character        150    1. Can be Null
Team (Post-Surgery) - Other,    OSTSURG98                               2. Cannot be Null if REASONNOMDTPOSTSURG = 98 (Other, specify)
specify
Care Team Meeting Actions       MDTACTPOSTSUR   Character           2   1.   Must be a valid code as listed in the national data definitions                         72
Recorded (Post-Surgery)         G                                       2.   Must be on or after DSURG
                                                                        3.   Can be 96 (Not applicable)
                                                                        4.   Can be 99 (Not known)
Histology (Post-Surgical)       SURGHIST        Character           2   1. Must be a valid code as listed in the national data definitions                           73
                                                                        2. If SURGHIST is recorded 10 (Inapplicable) then SURG must be 2 (No – reason documented)
                                                                           or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No) and
                                                                           DSURG, SURGTYPE, RESIDUAL, PTLUNG, PNLUNG and PMLUNG or PTMESO,
                                                                           PNMESO, PMMESO should all be coded as inapplicable

Residual Tumour                 RESIDUAL        Character           2   1. Must be a valid code as listed in the national data definitions                           75
                                                                        2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
TNM Tumour Classification       PTLUNG          Character           3   1. Must be a valid code as listed in the national data definitions                           76
(Pathological) (Lung Cancer)                                            2. If PTLUNG is recorded 96 (Not applicable) then SURG must be 2 (No – reason documented)
                                                                           or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No) and
                                                                           DSURG, SURGTYPE, RESIDUAL, PNLUNG and PMLUNG should all be coded as
                                                                           inapplicable
TNM Nodal Classification        PNLUNG          Character           2   1. Must be a valid code as listed in the national data definitions                           78
(Pathological) (Lung Cancer)                                            2. If PNLUNG is recorded 96 (Not applicable) then SURG must be 2 (No – reason documented)
                                                                           or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No)and
                                                                           DSURG, SURGTYPE, RESIDUAL, SURGHIST, PTLUNG and PM LUNG should all be coded
                                                                           as inapplicable
TNM Metastases Classification   PMLUNG          Character           3   1. Must be a valid code as listed in the national data definitions                           79
(Pathological) (Lung Cancer)                                            2. If PMLUNG is recorded 96 (Not applicable) then SURG must be 2 (No – reason documented)
                                                                           or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No) and
                                                                           DSURG, SURGTYPE, RESIDUAL, SURGHIST, PTLUNG and PNLUNG should all be coded
                                                                           as inapplicable



                                                National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                Developed by ISD Scotland, 2010 Version 2.1


                                                                                      Page 9
TNM Tumour Classification         PTMESO       Character           3   1. Must be a valid code as listed in the national data definitions                           80
(Pathological) {Pleural                                                2. If PTMESO is recorded 96 (Not applicable) then SURG must be 2 (No – reason documented)
Mesothelioma}                                                             or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No) and
                                                                          DSURG, SURGTYPE, RESIDUAL, SURGHIST, PNLUNG and PMLUNG should be coded as
                                                                          inapplicable
TNM Nodal Classification          PNMESO       Character           2   1. Must be a valid code as listed in the national data definitions                           82
(Pathological) {Pleural                                                2. If PNMESO is recorded 96 (Not applicable) then SURG must be 2 (No – reason documented)
Mesothelioma}                                                             or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No) and
                                                                          DSURG, SURGTYPE, RESIDUAL, SURGHIST, PTMESO and PMMESO should be coded
                                                                          as inapplicable
TNM Metastases Classification     PMMESO       Character           2   1. Must be a valid code as listed in the national data definitions                           83
(Pathological) {Pleural                                                2. If PMMESO is recorded 96 (Not applicable) then SURG must be 2 (No – reason documented)
Mesothelioma}                                                             or 3 (No – reason not documented) or 95 (Patient refused), MULTIPLE must be 00 (No) and
                                                                          DSURG, SURGTYPE, RESIDUAL, SURGHIST, PTMESO and PNMESO should be coded as
                                                                          inapplicable
Section 6: Radiotherapy                                                                                                                                             84
Radiotherapy                      RADIO        Character           2   1. Must be a valid code as listed in the national data definitions                           85
                                                                       2. If RADIO is coded as 2 (No – reason documented) or 3 (No – reason not documented) or 95
                                                                          (Patient refused) then CHART and FRACSCHED1, FRACSCHED2 and FRACSCHED3 must
                                                                          be 00 (None) and RADIOTYPE1, RADIOSITE1, RSRTDATE1, RCOMPDATE1, TOTDOSE1,
                                                                          FRACTIONS1, RADIOTYPE2, RADIOSITE2, RSRTDATE2, RCOMPDATE2, TOTDOSE2,
                                                                          FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3
                                                                          and FRACTIONS3 should all be coded as inapplicable.

Patient Eligible for Continuous   CHART        Character           2   1. Must be a valid code as listed in the national data definitions                           86
Hyperfractionated Accelerated                                          2. Can be 99 (Not known)
Radiotherapy (CHART)
Radiotherapy Course Type 1        RADIOTYPE1   Character           3   1. Must be a valid code as listed in the national data definitions                           87
                                                                       2. If RADIOTYPE1 is coded as 96 (Not applicable) then RADIO must be 2 (No – reason
                                                                          documented) or 3 (No – reason not documented) or 95 (Patient refused), CHART and
                                                                          FRACSCHED1, FRACSCHED2 and FRACSCHED3 must be 00 (None) and RADIOSITE1,
                                                                          RSRTDATE1, RCOMPDATE1, TOTDOSE1, FRACTIONS1, RADIOTYPE2, RADIOSITE2,
                                                                          RSRTDATE2, RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3,
                                                                          RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should all be coded as
                                                                          inapplicable.




                                               National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                               Developed by ISD Scotland, 2010 Version 2.1


                                                                                    Page 10
Site of Radiotherapy 1            RADIOSITE1       Character           2   1. Must be a valid code as listed in the national data definitions                           88
                                                                           2. If RADIOSITE1 is coded as 96 (Not applicable) then RADIO must be 2 (No – reason
                                                                              documented) or 3 (No – reason not documented) or 95 (Patient refused), CHART and
                                                                              FRACSCHED1, FRACSCHED2 and FRACSCHED3 must be 00 (None) and RADIOTYPE1,
                                                                              RSRTDATE1, RCOMPDATE1, TOTDOSE1, FRACTIONS1, RADIOTYPE2, RADIOSITE2,
                                                                              RSRTDATE2, RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3,
                                                                              RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as
                                                                              inapplicable.

Site of Radiotherapy 1 - Other,   RADIOSITEOTHER   Character        150    1. Can be Null
specify                           1                                        2. Cannot be Null if RADIOSITE1 = 98 (Other, specify)
Date Treatment Started            RSRTDATE1        Date              10    1. Format DD/MM/CCYY                                                                         89
(Radiotherapy) 1                                                           2. Must be a valid date on or before today’s date
                                                                           3. Can be 10/10/1010 (Not applicable)
                                                                           4. If RSRTDATE1 is coded as 10/10/1010 (Not applicable) then RADIO must be 2 (No – reason
                                                                              documented) or 3 (No – reason not documented) or 95 (Patient refused), CHART and
                                                                              FRACSCHED1, FRACSCHED2 and FRACSCHED3 must be 00 (None) and RADIOTYPE1,
                                                                              SITE1, RCOMPDATE1, TOTDOSE1, FRACTIONS1, RADIOTYPE2, RADIOSITE2,
                                                                              RSRTDATE2, RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3,
                                                                              RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as
                                                                              inapplicable.
                                                                           5. Can be 09/09/0909 (Not known)
                                                                           6. Must be on or before date of death

Date Treatment Completed          RCOMPDATE1       Date              10    1. Format DD/MM/CCYY                                                                         90
(Radiotherapy) 1                                                           2. Must be a valid date on or before today’s date
                                                                           3. Can be 10/10/1010 (Not applicable)
                                                                           4. If RCOMPDATE1 is coded as 10/10/1010 (Not applicable) then RADIO must be 2 (No –
                                                                              reason documented) or 3 (No – reason not documented) or 95 (Patient refused), CHART and
                                                                              FRACSCHED1, FRACSCHED2 and FRACSCHED3 must be 00 (None) and RADIOTYPE1,
                                                                              RADIOSITE1, RSRTDATE1, TOTDOSE1, FRACTIONS1, RADIOTYPE2, RADIOSITE2,
                                                                              RSRTDATE2, RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3,
                                                                              RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as
                                                                              inapplicable.
                                                                           5. Can be 09/09/0909 (Not known)
                                                                           6. Must be on or before date of death




                                                   National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                   Developed by ISD Scotland, 2010 Version 2.1


                                                                                        Page 11
Radiotherapy Dose: Total        TOTDOSE1       Numeric             5   1. Format nn.nn (up to 2 decimal places)                                                  91
Administered 1                                 Float nn.nn             2. Can be 96 (Not applicable)
                                                                       3. If TOTDOSE1 is coded as 96 (Not applicable) then RADIO must be 2 (No – reason
                                                                          documented) or 3 (No – reason not documented) or 95 (Patient refused), CHART and
                                                                          FRACSCHED1, FRACSCHED2 and FRACSCHED3 must be 00 (None) and RADIOTYPE1,
                                                                          RADIOSITE1, RSRTDATE1, RCOMPDATE1, FRACTIONS1, , RADIOTYPE2, RADIOSITE2,
                                                                          RSRTDATE2, RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3,
                                                                          RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as
                                                                          inapplicable.
                                                                       4. Can be 99 (Not known)

Radiotherapy Fractions: Total   FRACTIONS1     Numeric             2   1. Can be a number                                                                        92
Administered 1                                 (Integer)               2. Can be 96 (Not applicable)
                                                                       3. If FRACTIONS1 is coded as 96 then RADIO must 2 (No – reason documented) or 3 (No –
                                                                          reason not documented) or 95 (Patient refused), CHART and FRACSCHED1, FRACSCHED2
                                                                          and FRACSCHED3 must be 00 (None) and RADIOTYPE1, RADIOSITE1, RSRTDATE1,
                                                                          RCOMPDATE1, TOTDOSE1, RADIOTYPE2, RADIOSITE2, RSRTDATE2, RCOMPDATE2,
                                                                          TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3,
                                                                          TOTDOSE3 and FRACTIONS3 should be coded as inapplicable.
                                                                       4. Can be 99 (Not known)


Type of Radiofractionation      FRACSCHED1     Character           2   1. Must be a valid code as listed in the national data definitions                        93
Schedule 1                                                             2. If FRACSCHED1 is coded as 00 (None) then RADIO must be 2 (No – reason documented) or
                                                                          3 (No – reason not documented) or 95 (Patient refused), CHART must be 00 (No),
                                                                          FRACSCHED2 and FRACSCHED3 must be 00 (None) and RADIOTYPE1, RADIOSITE1,
                                                                          RSRTDATE1, RCOMPDATE1, TOTDOSE1, FRACTIONS1, RADIOTYPE2, RADIOSITE2,
                                                                          RSRTDATE2, RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3,
                                                                          RSRTDATE3, RCOMPDATE3, TOTDOSE3, FRACTIONS3 should be coded as inapplicable.


Type of Radiofractionation      FRACSCHED981   Character        150    1.   Can be Null
Schedule 1 - Other, specify                                            2.   Cannot be Null if FRACSCHED1 = 98 (Other, specify)
Radiotherapy Course Type 2      RADIOTYPE2     Character           3   1.   Must be a valid code as listed in the national data definitions                      87
                                                                       2.   If RADIOTYPE2 is coded as 96 (Not applicable) then FRACSCHED2 and FRACSCHED3
                                                                            must be 00 (None) and RADIOSITE2, RSRTDATE2, RCOMPDATE2, TOTDOSE2,
                                                                            FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3
                                                                            and FRACTIONS3 should be coded as inapplicable.

                                               National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                               Developed by ISD Scotland, 2010 Version 2.1


                                                                                    Page 12
Site of Radiotherapy 2            RADIOSITE2       Character           2   1. Must be a valid code as listed in the national data definitions                     88
                                                                           2. If RADIOSITE2 is coded as 96 (Not applicable) then FRACSCHED2 and FRACSCHED3 must
                                                                              be 00 (None) and RADIOTYPE2, RADIOSITE2, RSRTDATE2, RCOMPDATE2, TOTDOSE2,
                                                                              FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3
                                                                              and FRACTIONS3 should be coded as inapplicable.

Site of Radiotherapy 2 - Other,   RADIOSITEOTHER   Character        150    1. Can be Null
specify                           2                                        2. Cannot be Null if RADIOSITE2 = 98 (Other, specify
Date Treatment Started            RSRTDATE2        Date              10    1. Format DD/MM/CCYY                                                                   89
(Radiotherapy) 2                                                           2. Must be a valid date on or before today’s date
                                                                           3. Can be 10/10/1010 (Not applicable)
                                                                           4. If RSRTDATE2 is coded as 10/10/1010 (Not applicable) then FRACSCHED2 and
                                                                              FRACSCHED3 must be 00 (None) and RADIOTYPE2, RADIOSITE2, RSRTDATE2,
                                                                              RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3,
                                                                              RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as inapplicable.
                                                                           5. Can be 09/09/0909 (Not known)
                                                                           6. Must be on or before date of death

Date Treatment Completed          RCOMPDATE2       Date              10    1. Format DD/MM/CCYY                                                                   90
(Radiotherapy) 2                                                           2. Must be a valid date before today’s date
                                                                           3. Can be 10/10/1010 (Not applicable)
                                                                           4. If RCOMPDATE2 is coded as 10/10/1010 (Not applicable) then FRACSCHED2 and
                                                                              FRACSCHED3 must be 00 (None) and RADIOTYPE2, RADIOSITE2, RSRTDATE2,
                                                                              RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3,
                                                                              RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as inapplicable.
                                                                           5. Can be 09/09/0909 (Not known)
                                                                           6. Must be on or before date of death

Radiotherapy Dose: Total          TOTDOSE2         Numeric             5   1. Format nn.nn (up to 2 decimal places)                                               91
Administered 2                                     nn.nn                   2. Can be 96 (Not applicable)
                                                                           3. If TOTDOSE2 is coded as 96 (Not applicable) then FRACSCHED2 and FRACSCHED3 must
                                                                              be 00 (None) and RADIOTYPE2, RADIOSITE2, RSRTDATE2, RCOMPDATE2, TOTDOSE2,
                                                                              FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3
                                                                              and FRACTIONS3, should be coded as inapplicable.
                                                                           4. Can be 99 (Not known)




                                                   National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                   Developed by ISD Scotland, 2010 Version 2.1


                                                                                        Page 13
Radiotherapy Fractions: Total     FRACTIONS2       Numeric             2   1. Can be a number                                                                          92
Administered 2                                     (Integer)               2. Can be 96 (Not applicable)
                                                                           3. If FRACTIONS2 is coded as 96 (Not applicable) then FRACSCHED2 and FRACSCHED3
                                                                               must be 00 (None) and RADIOTYPE2, RADIOSITE2, RSRTDATE2, RCOMPDATE2,
                                                                               TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3,
                                                                               TOTDOSE3, FRACTIONS3 should be coded as inapplicable.
                                                                           4. Can be 99 (Not known)

Type of Radiofractionation        FRACSCHED2       Character           2   1. Must be a valid code as listed in the national data definitions                          93
Schedule 2                                                                 2. If FRACSCHED2 is coded as 00 (None) then FRACSCHED3 must be 00 (None) and RADIO
                                                                              must be 2 (No – reason documented) or 3 (No – reason not documented) or 95 (Patient
                                                                              refused), CHART must be 00 (No) and RADIOTYPE2, RADIOSITE2, RSRTDATE2,
                                                                              RCOMPDATE2, TOTDOSE2, FRACTIONS2, RADIOTYPE3, RADIOSITE3, RSRTDATE3,
                                                                              RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as inapplicable.

Type of Radiofractionation        FRACSCHED982     Character        150    1.   Can be Null
Schedule 2 - Other, specify                                                2.   Cannot be Null if FRACSCHED2 = 98 (Other, specify)
Radiotherapy Course Type 3        RADIOTYPE3       Character           2   1.   Must be a valid code as listed in the national data definitions                        87
                                                                           2.   If RADIOTYPE3 is coded as 96 (Not applicable) then FRACSCHED 3 must be 00 (None) and
                                                                                RADIOTYPE3, SITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should
                                                                                be coded as inapplicable.
Site of Radiotherapy 3            RADIOSITE3       Character           2   1.   Must be a valid code as listed in the national data definitions                        88
                                                                           2.   If RADIOSITE3 is coded as 96 (Not applicable) then FRACSCHED3 must be 00 (None) and
                                                                                RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3 and
                                                                                FRACTIONS3, should be coded as inapplicable.
Site of Radiotherapy 3 - Other,   RADIOSITEOTHER   Character        150    1.   Can be Null
specify                           3                                        2.   Cannot be Null if RADIOSITE3 = 98 (Other, specify)
Date Treatment Started            RSRTDATE3        Date              10    1.   Format DD/MM/CCYY                                                                      89
(Radiotherapy) 3                                                           2.   Must be a valid date before today’s date
                                                                           3.   Can be 10/10/1010 (Not applicable)
                                                                           4.   Can be 09/09/0909 (Not known)
                                                                           5.   If RSRTDATE3 is coded as 10/10/1010 (Inapplicable) then FRACSCHED3 must be 00 (None)
                                                                                and RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3 and
                                                                                FRACTIONS3, should be coded as inapplicable.
                                                                           6.   Must be on or before date of death




                                                   National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                   Developed by ISD Scotland, 2010 Version 2.1


                                                                                        Page 14
Date Treatment Completed        RCOMPDATE3     Date              10    1. Format DD/MM/CCYY                                                                        90
(Radiotherapy) 3                                                       2. Must be a valid date on or before today’s date
                                                                       3. Can be 10/10/1010 (Not applicable)
                                                                       4. If RCOMPDATE3 is coded as 10/10/1010 (Inapplicable) then FRACSCHED3 must be 00
                                                                          (None) and RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3 and
                                                                          FRACTIONS3, should be coded as inapplicable.
                                                                       5. Can be 09/09/0909 (Not known)
                                                                       6. Must be on or before date of death

Radiotherapy Dose: Total        TOTDOSE3       Numeric             5   1. Format nn.nn (up to 2 decimal places)                                                    91
Administered 3                                 Float nn.nn             2. Can be 96 (Not applicable)
                                                                       3. If TOTDOSE3 is coded as 96 (Not applicable) then FRACSCHED3 must be 00 (None) and
                                                                          RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3 and
                                                                          FRACTIONS3, should be coded as inapplicable (96).
                                                                       4. Can be 99 (Not known)
Radiotherapy Fractions: Total   FRACTIONS3     Numeric             2   1. Can be a number                                                                          92
Administered 3                                 (Integer)               2. Can be 96 (Not applicable)
                                                                       3. If FRACTIONS3 is coded as 96 (Not applicable) then FRACSCHED3 must be 00 (None) and
                                                                          RADIOTYPE3, RADIOSITE3, RSRTDATE3, RCOMPDATE3, TOTDOSE3 and FRACTIONS3
                                                                          should be coded as inapplicable.
                                                                       4. Can be 99 (Not known)
Type of Radiofractionation      FRACSCHED3     Character           2   1. Must be a valid code as listed in the national data definitions                          93
Schedule 3                                                             2. If FRACSCHED3 is coded as 00 (None) then RADIOTYPE3, RADIOSITE3, RSRTDATE3,
                                                                          RCOMPDATE3, TOTDOSE3 and FRACTIONS3 should be coded as inapplicable.

Type of Radiofractionation      FRACSCHED983   Character        150    1. Can be Null
Schedule 3 - Other, specify                                            2. Cannot be Null if FRACSCHED3 = 98 (Other, specify)
Section 7: Systemic Therapy                                                                                                                                        94
Treatment Status {Cancer}       CHEM           Character           2   1. Must be a valid code as listed in the national data definitions                          95
(Systemic Therapy)                                                     2. If CHEM is coded as 2 (No – reason documented) or 3 (No – reason not documented) or 95
                                                                          (Patient refused), then CHEMTYPE1, CHEMAGENT1, CYCLES1, CHEMDATE1,
                                                                          CHEMENDATE1, CHEMTYPE2, CHEMAGENT2, CYCLES2, CHEMDATE1,
                                                                          CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3 and
                                                                          CHEMENDATE3 should be coded as inapplicable




                                               National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                               Developed by ISD Scotland, 2010 Version 2.1


                                                                                    Page 15
Systemic Therapy Type {Cancer}    CHEMTYPE1      Character           2   1. Must be a valid code as listed in the national data definitions                         96
1                                                                        2. If CHEMTYPE1 is coded as 96 (Not applicable) then CHEM must be 2 (No – reason
                                                                            documented) or 3 (No – reason not documented) or 95 (Patient refused), and
                                                                            CHEMAGENT1, CYCLES1, CHEMDATE1, CHEMENDATE1, CHEMTYPE2, CHEMAGENT2,
                                                                            CYCLES2, CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3,
                                                                            CHEMDATE3 and CHEMENDATE3 should be coded as inapplicable

Systemic Therapy Agent {Lung      CHEMAGENT1     Character           2   1. Must be a valid code as listed in the national data definitions                         97
Cancer} 1                                                                2. If CHEMAGENT1 is coded as 96 (Not applicable) then CHEM must be 2 (No – reason
                                                                            documented) or 3 (No – reason not documented) or 95 (Patient refused), and CHEMTYPE1,
                                                                            CYCLES1, CHEMDATE1, CHEMENDATE1, CHEMTYPE2, CHEMAGENT2, CYCLES2,
                                                                            CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3
                                                                            and CHEMENDATE3 should be coded as inapplicable

Systemic Therapy Agent 1 -                       Character        150    1. Can be Null
Other, specify                    CHEMAGENT981                           2. Cannot be Null if CHEMAGENT1 = 98 (Other, specify)
Chemotherapy Total Number of      CYCLES1        Numeric             3   1. Can be a number                                                                         98
Cycles Administered {Cancer} 1                   (Integer)               2. Can be X96 (Not applicable)
                                                                         3. If CYCLES1 is coded as X96 (Not applicable) then CHEM must be 2 (No – reason
                                                                            documented) or 3 (No – reason not documented) or 95 (Patient refused), and CHEMTYPE1,
                                                                            CHEMAGENT1, CHEMDATE1, CHEMENDATE1, CHEMTYPE2, CHEMAGENT2,
                                                                            CYCLES2, CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3,
                                                                            CHEMDATE3 and CHEMENDATE3 should be coded as inapplicable
                                                                         4. Can be X99 (Not known)

Date Treatment Started {Cancer}   CHEMDATE1      Date              10    1. Format DD/MM/CCYY                                                                       99
(Systemic Therapy) 1                                                     2. Must be a valid date on or before today’s date
                                                                         3. Can be 10/10/1010 (Not applicable)
                                                                         4. If CHEMDATE1 is coded as 10/10/1010 (Not applicable) then CHEM must be 2 (No – reason
                                                                            documented) or 3 (No – reason not documented) or 95 (Patient refused), and CHEMTYPE1,
                                                                            CHEMAGENT1, CYCLES1, CHEMENDATE1, CHEMTYPE2, CHEMAGENT2, CYCLES2,
                                                                            CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3
                                                                            and CHEMENDATE3 should be coded as inapplicable
                                                                         5. Can be 09/09/0909 (Not known)
                                                                         6. Must be on or before date of death




                                                 National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                 Developed by ISD Scotland, 2010 Version 2.1


                                                                                      Page 16
Date Treatment Completed          CHEMENDATE1    Date              10    1. Format DD/MM/CCYY                                                                    100
{Cancer} (Systemic Therapy) 1                                            2. Must be a valid date on or before today’s date
                                                                         3. Can be 10/10/1010 (Not applicable)
                                                                         4. If CHEMENDATE1 is coded as 10/10/1010 then CHEM must be 2 (No – reason documented)
                                                                            or 3 (No – reason not documented) or 95 (Patient refused), and CHEMTYPE1,
                                                                            CHEMAGENT1, CYCLES1, CHEMDATE1, CHEMTYPE2, CHEMAGENT2, CYCLES2,
                                                                            CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3
                                                                            and CHEMENDATE3 should be coded as inapplicable
                                                                         5. Can be 09/09/0909 (Not known)
                                                                         6. Must be on or before date of death

Systemic Therapy Type {Cancer}    CHEMTYPE2      Character           2   1. Must be a valid code as listed in the national data definitions                       96
2                                                                        2. If CHEMTYPE2 is coded as 96 (Not applicable) then CHEMAGENT2, CYCLES2,
                                                                            CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3
                                                                            and CHEMENDATE3 should be coded as inapplicable

Systemic Therapy Agent {Lung      CHEMAGENT2     Character           2   1. Must be a valid code as listed in the national data definitions                       97
Cancer} 2                                                                2. If CHEMAGENT2 is coded as 96 (Not applicable) then CHEMTYPE2, CYCLES2,
                                                                            CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3
                                                                            and CHEMENDATE3 should be coded as inapplicable

Systemic Therapy Agent 2 -        CHEMAGENT982   Character        150    1. Can be Null
Other, specify                                                           2. Cannot be Null if CHEMAGENT2 = 98 (Other, specify)
Chemotherapy Total Number of      CYCLES2        Numeric             3   1. Can be a number                                                                      98
Cycles Administered {Cancer} 2                   (Integer)               2. Can be X96 (Not applicable)
                                                                         3. If CYCLES2 is coded as X96 (Not applicable) then CHEMTYPE2, CHEMAGENT2,
                                                                            CHEMDATE2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3
                                                                            and CHEMENDATE3 should be coded as inapplicable
                                                                         4. Can be X99 (Not known)

Date Treatment Started {Cancer}   CHEMDATE2      Date              10    1. Format DD/MM/CCYY                                                                    99
(Systemic Therapy) 2                                                     2. Must be a valid date on or before today’s date
                                                                         3. Can be 10/10/1010 (Not applicable)
                                                                         4. If CHEMDATE2 is coded as 10/10/1010 (Not applicable) then CHEMTYPE2, CHEMAGENT2,
                                                                            CYCLES2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3, CHEMDATE3 and
                                                                            CHEMENDATE3 should be coded as inapplicable
                                                                         5. Can be 09/09/0909 (Not known)
                                                                         6. Must be on or before date of death


                                                 National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                 Developed by ISD Scotland, 2010 Version 2.1


                                                                                      Page 17
Date Treatment Completed          CHEMENDATE2    Date              10    1. Format DD/MM/CCYY                                                                  100
{Cancer} (Systemic Therapy) 2                                            2. Must be a valid date before today’s date
                                                                         3. Can be 10/10/1010 (Not applicable)
                                                                         4. If CHEMENDATE2 is coded as 10/10/1010 (Not applicable) then CHEMTYPE2,
                                                                            CHEMAGENT2, CYCLES2, CHEMENDATE2, CHEMTYPE3, CHEMAGENT3, CYCLES3,
                                                                            CHEMDATE3 and CHEMENDATE3 should be coded as inapplicable
                                                                         5. Can be 09/09/0909 (Not known)
                                                                         6. Must be on or before date of death

Systemic Therapy Type {Cancer}    CHEMTYPE3      Character           2   1. Must be a valid code as listed in the national data definitions                     96
3                                                                        2. If CHEMTYPE3 is coded as 96 (Not applicable) then CHEMAGENT3, CYCLES3,
                                                                            CHEMDATE3 and CHEMENDATE3 should be coded as inapplicable

Systemic Therapy Agent {Lung      CHEMAGENT3     Character           2   1. Must be a valid code as listed in the national data definitions                     97
Cancer} 3                                                                2. If CHEMAGENT3 is coded as 96 (Not applicable) then CHEMTYPE3, CYCLES3,
                                                                            CHEMDATE3 and CHEMENDATE3 should be coded as inapplicable

Systemic Therapy Agent 3 -        CHEMAGENT983   Character        150    1. Can be Null
Other, specify                                                           2. Cannot be Null if CHEMAGENT3 = 98 (Other, specify)
Chemotherapy Total Number of      CYCLES3        Numeric             3   1. Can be a number                                                                    98
Cycles Administered {Cancer} 3                   (Integer)               2. Can be X96 (Not applicable)
                                                                         3. If CYCLES3 is coded as X96 (Not applicable) then CHEMTYPE3, CHEMAGENT3,
                                                                            CHEMDATE3 and CHEMENDATE3 should be coded as inapplicable
                                                                         4. Can be X99 (Not known)

Date Treatment Started {Cancer}   CHEMDATE3      Date              10    1. Format DD/MM/CCYY                                                                  99
(Systemic Therapy) 3                                                     2. Must be a valid date on or before today’s date
                                                                         3. Can be 10/10/1010 (Not applicable)
                                                                         4. If CHEMDATE3 is coded as 10/10/1010 (Not applicable) then CHEMTYPE3, CHEMAGENT3,
                                                                            CYCLES3 and CHEMENDATE3 should be coded as inapplicable
                                                                         5. Can be 09/09/0909 (Not known)
                                                                         6. Must be on or before date of death




                                                 National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                 Developed by ISD Scotland, 2010 Version 2.1


                                                                                      Page 18
Date Treatment Completed          CHEMENDATE3   Date              10    1. Format DD/MM/CCYY                                                        100
{Cancer} (Systemic Therapy) 3                                           2. Must be a valid date on or before today’s date
                                                                        3. Can be 10/10/1010 (Not applicable)
                                                                        4. If CHEMENDATE3 is coded as 10/10/1010 (Not applicable) then CHEMTYPE3,
                                                                           CHEMAGENT3, CYCLES3 and CHEMDATE3 should be coded as inapplicable
                                                                        5. Can be 09/09/0909 (Not known)
                                                                        6. Must be on or before date of death

Section 8: Other Therapy                                                                                                                            101
Date of Endobronchial Treatment   ENDODATE      Date              10    1. Format DD/MM/CCYY                                                        102
                                                                        2. Must be a valid date on or before today’s date
                                                                        3. Must be on or before date of death
Section 9: Clinical Trials                                                                                                                          103
Participant in Clinical Trials    TENTRY        Character           2   1. Must be a valid code as listed in the national data definitions          104
                                                                        2. Can be 96 (Not applicable)
                                                                        3. Can be 99 (Not known)
Section 10: Follow-Up and                                                                                                                           105
Death
Date of Death                     DOD           Date              10    1.   Format DD/MM/CCYY                                                      106
                                                                        2.   Must be a valid date on or before today’s date
                                                                        3.   Can be 10/10/1010 (Not applicable)
                                                                        4.   Can be 09/09/0909 (Not known)
Underlying Cause of Death         COD           Character           4   1.   Must be a valid code as listed in the national data definitions        107
                                                                        2.   Format: alphanumeric ann.n or ann.a e.g. C34.9
                                                                        3.   Can be 96 (Not applicable)
                                                                        4.   Can be 99 (Not known)




                                                National Data Definitions for National Minimum Core Data Set for Lung Cancers
                                                                Developed by ISD Scotland, 2010 Version 2.1


                                                                                     Page 19

				
DOCUMENT INFO
Categories:
Tags:
Stats:
views:16
posted:6/26/2012
language:English
pages:141
jolinmilioncherie jolinmilioncherie http://
About